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“It is evident that the problem 
 of categorizing FHR patterns  
in a meaningful and objective way  
will be a sizable task.” 
Edward Hon 1963 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
“This is adding apples and oranges to pears 
and comparing them to grapefruit.” 
Dr Preston’s criticism on the  
Denver study 1979 
 
 
 
 
 
 
 
 
 
 
 
  
  
  
  
 
 
 
 
 
 
 
 
 
 
To meet the eyes of a newborn baby 
Pure magic – the world stops turning 
 
How can eyes that have seen nothing 
Be filled with oceans and stars 
 
To share these moments 
Every day at work 
Is the greatest 
Privilege 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
To my parents 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
ABSTRACT 
Background: Cardiotocography (CTG) is the main method for intrapartum fetal surveillance in 
many countries. The method has a high sensitivity, but a poor specificity, which leads to an 
increased rate of interventions compared with auscultation. Fetal scalp blood sampling (FBS) 
was developed parallel to CTG, and can be used as an adjunct to diagnose or exclude fetal 
acidemia when the CTG tracing is non-reassuring. Lactate analysis has been shown as reliable 
as gold standard pH analysis, and FBS with lactate analysis has the advantages of a lower 
failure rate, shorter time from sampling to analysis result, and lactate concentration identifies 
the metabolic component of acidemia in contrast to pH. However, since guidelines for CTG 
interpretation cannot be regarded as fully evidence-based, neither can guidelines for the use of 
FBS. The aim of this thesis was to further increase the knowledge of FBS and measurements of 
fetal lactate concentrations as an adjunct in intrapartum fetal surveillance. 
Materials and Methods: The study populations consisted of women with a simplex pregnancy, 
gestational age ≥34 weeks, cephalic presentation and indication for FBS during labor. The 
cohort in studies I and II were women who had participated in a former RCT at ten obstetric 
units in Sweden. Study I included all 2992 women randomized to either pH-, or lactate analysis, 
and Study II included the 1496 women with lactate analysis. The cohort in studies III and IV 
were all consecutive women with FBS during labor at Karolinska University Hospital Solna, 
Sweden, during two years. In the 1
st
 cohort, the 95
th
 percentile of all lactate values and the 5
th
 
percentile of all pH values were used as the definition of severe intrapartum acidemia and 
frequencies of adverse neonatal outcome were calculated. The neonates were classified 
according to birth weight as small/appropriate/large, and medians in lactate concentration at 
FBS were calculated in the total population as well as in acidemic cases. Neonatal outcome was 
analyzed according to birth weight groups. In the 2
nd
 cohort, all CTG traces prior to FBSs were 
interpreted, and CTG patterns were correlated to acidemia at FBS. Delivery mode and neonatal 
outcome were analyzed in relation to number of FBSs during labor, 1-2 vs ≥ 3. 
Results: The risk of serious adverse neonatal outcome was 10 % or less in the high risk groups 
with severe intrapartum acidemia, and time interval from FBS to delivery was shorter in the pH 
group. In comparison between birth weight groups, the median lactate concentration at FBS in 
acidemic fetuses did not differ, nor did the proportion of acidemic fetuses at FBS or neonatal 
outcome. A CTG tracing with isolated reduced variability did not increase the risk of acidemia 
at FBS, severe variable decelerations and late decelerations correlated equally to acidemia, and 
tachycardia with either of those decelerations had the highest prevalence of acidemia. Neonatal 
outcome did not differ in labors with ≥ 3 FBS compared with 1-2 FBS, but cesarean delivery 
rate was 42 % vs 23 %, with an adjusted odds ratio of 2.0. 
Conclusions: Acidemia in scalp blood is an early marker of intrapartum fetal hypoxia, and FBS 
can be used to prevent severe birth acidemia. Lactate might react earlier than pH in the hypoxic 
process. Small for gestational age fetuses can produce equally amounts of lactate as a response 
to hypoxia as normally grown fetuses, and FBS with lactate analysis is a reliable surveillance 
method also for growth restricted fetuses in labor. A CTG tracing with isolated reduced 
variability does not necessitate repeated FBS during labor. The two types of serious 
decelerations correspond equally to fetal acidemia and distinguishing them is not crucial. 
Monitoring women with repeated FBS during labors with CTG changes is safe for the fetus, but 
the rate of cesarean delivery is doubled as compared to labors where 1-2 FBS are needed. 
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BACKGROUND 
INTRODUCTION 
For the majority of fetuses, pregnancy is a period of uncomplicated growth and 
maturation of organs, with labor as the first challenge to the fetal reserves. Most fetuses 
start labor in a vigorous state, and cope well with the intermittent reduction in oxygen 
supply during labor contractions. Fetuses with reduced capacity to endure the stress of 
being born are exposed to the risk of hypoxic organ damage with lifelong sequels i.e. 
cerebral palsy.   
Cardiotocography (CTG) was introduced with great expectations of reducing the rates 
of neonatal mortality and cerebral palsy, but randomized trials have failed to show an 
effect on those two outcomes when compared to intermittent auscultation.
1
 Intrapartum 
hypoxia is only a minor contributor to cerebral palsy, whereas antenatal causes are 
more common.
2
 However, also rare outcomes, when severe with long-lasting 
consequences, are important goals of preventive measures. 
 
CTG is generally considered an important screening instrument, with very good 
negative predictive ability, but due to the high rate of false positive tests, CTG 
monitoring is associated with increased rates of cesarean deliveries in comparison with 
intermittent auscultation.
1
 Fetal scalp blood sampling (FBS) was developed as a 
method of intrapartum fetal monitoring parallel to CTG, and can discriminate which 
fetuses that are acidemic and which are not in labors with a non-reassuring CTG trace. 
FBS is used and considered as a valuable adjunct to CTG in some countries,
3, 4
 but 
considered of no additional benefit in other countries.
5
 However, there are no studies 
that have been designed to address the impact of FBS on cesarean rate. 
 
If a vigorous fetus enters labor and there is a successive development of hypoxia, fetal 
monitoring with CTG and FBS are preventive tools to enable timely intervention and 
delivery of a healthy non-acidemic child. If a fetus entering labor already has been 
exposed to antenatal hypoxia, the fetal monitoring can be used to prevent further 
damage. In cases with a sudden obstetric catastrophe as placental abruption, uterine 
rupture or umbilical cord prolapse, there is little room for preventive measures, and no 
indication for FBS. 
 
 
FETAL METABOLISM AND ACID-BASE BALANCE 
Fetal circulation 
Fetal circulation differs from adult circulation since the oxygenation of blood takes 
place in the placenta instead of in the lungs. There are three essential short-cuts in the 
fetal circulation (ductus venosus, foramen ovale and ductus arteriosus); all with the 
obvious purpose to prioritize well oxygenated blood to the fetal brain and heart. The 
short-cuts are schematically illustrated in Figure 1. 
The umbilical vein transports the oxygenated blood from the placenta to the fetus, 
firstly passing through the fetal liver. The umbilical vein divides into the two branches 
supplying left and right sides of the liver, and the first short-cut – the ductus venosus, 
with approximately 20 % of the blood thereby bypassing the liver in term fetuses. This 
 2 
fraction can increase during hypoxia, probably up to 50 %.
6
 The blood mixes with 
deoxygenated blood when ductus venosus enters the thoracic portion of vena cava 
inferior, which carries blood from peripheral tissues, and where the hepatic veins also 
connects.  
 
Figure 1. Schematic illustration of the short-cuts in fetal circulation. 
   
 
Animal studies have shown that the stream with well oxygenated blood from the ductus 
venosus preferably takes the next short-cut in the fetal heart; from the right atrium 
through foramen ovale to the left atrium and ventricle, and goes directly to central and 
peripheral tissues without passing the lungs.
7, 8
 The stream of deoxygenated blood 
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coming into the right atrium from the superior and inferior venae cavae enters the right 
ventricle and pulmonary trunk, and at this point the blood can take a third short-cut into 
the systemic circulation through ductus arteriosus. This short-cut enters the aorta after 
the brachiocephalic trunk has parted, and thus further mixing with deoxygenated blood 
takes place after the branch that supports the brain has parted. From aorta, via the 
internal iliac arteries, blood returns to placenta in the two umbilical arteries, which 
thereby carry mixed blood on the way from the fetal heart to peripheral tissues. The 
deoxygenated blood coming from peripheral tissues enters the inferior and superior 
venae cava, going back to the fetal heart, mixing with oxygenated blood in the right 
atrium. Therefore, most of the fetal tissues are supplied with mixed oxygenated and 
deoxygenated i.e. “used” blood.  
 
There is limited access to the fetus prior to the onset of labor, and antenatal assessments 
include ultrasound measurements of blood flow in uterine arteries, umbilical arteries 
and vein, ductus venosus and arteria cerebri media. Fetal decompensation during labor 
can however be confirmed by blood gas and acid-base measurements of umbilical 
vessels immediately after delivery. As explained above, the umbilical vein blood 
thereby reflects the placental function, and the umbilical artery reflects the fetal status. 
 
In order to guarantee sufficient oxygen supply for cellular metabolism and energy 
production, the fetus is dependent on many different steps in the transport of oxygen. 
Maternal respiration and circulation, perfusion of, and gas-exchange over the placenta, 
circulation in the umbilical cord, and circulation in the fetus are all important factors. A 
complication in either of these steps can result in hypoxic / ischemic tissue injury. 
 
If the oxygen supply is restricted, the fetus has several compensatory mechanisms to 
maintain its intracellular energy production. Regarding fetal circulation, the stroke 
volume normally works near its functional limit, and cannot be increased as in adults, 
but the heart rate can be increased to increase cardiac output,
9
 and the blood flow can 
be redirected to vital organs such as the heart, brain and adrenals.
10-12
 Oxygen demand 
can also be lowered by decreased gross body and breathing movements,
13, 14
 and even 
reduced brain metabolism.
15
 On a cellular level, the fetus can utilize the Bohr effect i.e. 
reduced oxygen affinity to hemoglobin in more acidic environments. Fetal hemoglobin 
(HbF) otherwise has a higher oxygen affinity than adult hemoglobin (HbA), in order to 
optimize oxygen extraction in the placenta. 
 
Fetal metabolism 
Glucose is the main substrate for energy production. Through glycolysis, it is 
metabolized to pyruvate, and during this process a small amount of energy is produced 
in the form of two adenosine-triphosphate (ATP). Under aerobic circumstances, 
pyruvate enters the mitochondrion from the cytoplasm, and takes part in the citric acid 
cycle. Energy is produced in the form of 36 ATP, with the waste products carbon 
dioxide (CO2) and water (H2O). (Fig. 2) 
  
 4 
Figure 2. Glycolysis and aerobic metabolism 
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During the transport away from the tissue, CO2 dissolves in blood plasma and 
equilibrates with carbonic acid (H2CO3) which in turn equilibrates with its 
corresponding base bicarbonate (HCO3
-
) and the hydrogen ion (H
+
) (Figure 3).  
 
Figure 3. Equilibrium between carbon dioxide and hydrogen ions. 
 
 CO2 + H2O ↔ H2CO3 ↔ H
+
 + HCO3
-  
 
As shown in Fig 2, lactate is not only produced under anaerobic circumstances, but 
there is always a steady state between pyruvate and lactate, also during aerobic 
metabolism. The equilibrium is normally shifted to the right with a lactate/pyruvate 
ratio 10:1. In situations with a decreased energy demand, lactate can via a shift in the 
equilibrium convert back to pyruvate, which then converts further in the 
gluconeogenesis, and thus, lactate can be used as fuel and after glucose, lactate is the 
second most important carbohydrate fuel in the fetus. Gluconeogenesis mainly takes 
place in the liver and heart, and in the liver, glucose can be stored as glycogen.  
Maternal levels of lactate are 20-30% lower than in the fetus, but may increase in 
situations with intensive muscular activity, such as during labor. However, due to the 
slow transport of lactate over the placenta, this has limited effect on the fetal level.
16
 
There is also placental lactate production under aerobic conditions, and that lactate 
probably serves as fuel to the fetus,
17
  but it also enters the maternal circulation. Thus, 
under aerobic circumstances, there are equilibriums between mother, placenta and the 
fetus regarding lactate levels.  
 
Fetal acid-base balance 
pH and buffering systems 
The concentration of H
+
 is measured in pH, which is defined as the negative logarithm 
of H
+
 activity. A stable concentration of H
+
 in tissues is of outmost importance for 
cellular function, and all organisms have buffering systems to maintain the 
concentration within physiologic range. The two main systems in humans are 
bicarbonate and proteins. The sum of buffering capacity by HCO3
-
 and proteins 
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together is called the buffer base. HCO3
-
 is the most important buffer in extracellular 
fluid due to its high concentration. Intracellular buffers are proteins, and the most 
important protein buffer for the fetus is hemoglobin since concentrations of other 
buffering proteins are lower than in the adult. 
 
Base excess /base deficit 
When the buffering agents are consumed due to a lowered pH, this can be calculated by 
use of measured pH and CO2. Base excess (BE) is defined as the amount of acid or 
base required to restore pH to normal at a partial pressure of CO2 (pCO2) of 5.3 kPa at 
37°C, at the actual oxygen saturation of the blood, expressed in mmol/L.
18
 When BE is 
negative, i.e. there is a lack of buffer base due to metabolic acidosis, it is more 
convenient to use the term base deficit (BD).  
As mentioned, BD is not a direct measured value, but calculated in an algorithm with 
measured values of pH and CO2. BD measurement is affected by the hemoglobin 
concentration which is different in the fetus compared with the adult. When whole 
blood is used for the analysis, BD is also affected by the CO2 concentration, although it 
is supposed to measure only the metabolic component. If pCO2 increases, HCO3
-
 
increases and partly leaves the intravascular compartment to equilibrate with the rest of 
the extracellular fluid (ecf), and this shift of HCO3
-
 out of the blood will increase BD.
18
 
Siggaard-Andersen who developed the alignment nomogram for BE, proposed that the 
best way to eliminate that artifact was to consider the red cells as evenly distributed 
over the entire extracellular fluid. As the extravascular part is about twice that of the 
intravascular part, the correction was achieved by dividing the actual hemoglobin 
concentration by 3, and thus, the BEecf was calculated at a standard hemoglobin value 
of 50 g/L, and called standard BE (SBE). BEblood is often called actual BE (ABE).  
 
In spite of these arguments, most clinical studies on correlations between acidemia in 
umbilical cord artery and neonatal outcome are performed with BDblood, not least the 
voluminous work by Low et al.
19-21
 More recent work has shown a stronger correlation 
with neonatal outcome for BDblood than for BDecf which supports continued use of this 
compartment for BD measurements.
22
 Wiberg et al. also pointed out the importance of 
understanding the complexity of BD use, concerning BD not being a measured entity, 
but an estimate based on measured pH and pCO2, and thus, more sensitive for 
introducing error. Algorithms for BD calculations may also vary between different 
blood gas analyzers.
22
 
   
Respiratory acidemia 
As shown by Nijland et al, the fetal pH is not linearly correlated to oxygen saturation, 
and the partial pressure of oxygen (pO2) can decrease to values between 20% and 30% 
before anaerobic metabolism occurs, and thus metabolic acidemia.
9
 However, before 
the oxygen supply reaches this critical level, a respiratory acidemia can occur. If 
placental gas exchange is impaired, the CO2 will increase on the fetal side causing a 
respiratory acidemia, which is defined as reduced arterial pH due to an elevated partial 
pressure of CO2. The term ‘respiratory’ relates to the response in the adult with 
hyperventilation to eliminate excess CO2 which lowers pCO2 and causes a rise in pH. 
The fetus obviously cannot eliminate CO2 that way, but only through placental gas 
exchange. When this way of elimination is impaired, excess CO2 dissolves and the 
 6 
equilibration in Fig.3 shifts to the right. As HCO3
-
 is the main extracellular buffer, and 
the system cannot buffer itself, the excess H
+
 in respiratory acidemia can only be 
buffered by the protein system. However, when placental gas exchange is re-
established, CO2 diffuses rapidly across the placenta, and there is no evidence of tissue 
injury from isolated respiratory acidemia.
21
 
 
Metabolic acidemia 
Metabolic acidemia is defined as reduced pH caused by lack of buffer base, which is 
measured by increased BD. In a situation with restricted oxygen supply, cells switch 
from aerobic to anaerobic metabolism with the end products lactate
-
 and H
+
 (Figure 4). 
Energy production is much less, with only 2 ATP instead of 2 + 36 ATP, and the 
increased amounts of H
+
 consumes buffering agents leading to metabolic acidemia. 
  
Figure 4. Anaerobic metabolism 
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If oxygen supply is restored after an episode of hypoxia and anaerobic metabolism, 
pyruvate again enters the mitochondria from the cytosol, and therefore the equilibrium 
between lactate and pyruvate turns to the left, and lactate can be used in 
gluconeogenesis as explained above. The lactate/pyruvate ratio has been used as a 
measure of hypoxia since it increases during metabolic acidemia, however, it is not 
shown to perform better in predicting hypoxia than determination of lactate alone, and 
has never become part of clinical use.
16
 
Several animal and human studies have addressed the question of lactate origin when 
fetal lactate concentration is increased.
23-25
 Piquard et al. described several findings 
strongly indicating fetal origin as well in steady state labors as in labors complicated by 
acute stress conditions. They showed that the umbilical arteriovenous lactate 
differences were positive and large in all newborns and that a positive maternofetal 
gradient of lactate was rarely observed. In addition, there was only a very weak 
correlation between fetal and maternal lactate levels, indicating that the increase in 
lactate occurred independently in mother and fetus.
24
 Thus, a fast increase in lactate 
concentration as a response to a relatively sudden development of hypoxia, as during 
labor, can be regarded as of fetal origin. 
 
Intrauterine growth restriction and fetal acid-base status 
Fetuses exposed to chronic hypoxia have also been studied with measurements of 
lactate concentrations. In a study by Nicolaides et al., fetuses that were small for 
   7 
gestational age (SGA) were found to have hypoxemia, hypercapnia, hyperlactemia and 
acidosis.
26
 The authors explained the hypercapnia as due to reduced gas exchange over 
the malfunctioning placenta, motivated by significant correlation between the degree of 
hypercapnia and the increased resistance in the umbilical and uterine arteries in SGA 
pregnancies. The authors reported it to be unlikely that lactate measured in the SGA 
fetuses would be of placental origin, because maternal blood lactate was not higher in 
the group with SGA fetuses than the group with appropriate for gestational age (AGA) 
fetuses, and since there was no correlation between fetal and maternal blood lactate. 
Diagnosis of intrauterine growth restriction (IUGR) is not possible unless serial 
ultrasonographic measurements are performed, and SGA is commonly used as a proxy 
for IUGR. The cut off used in Sweden is fetal weight less than 2 standard deviations 
(SD) below the mean according to the Swedish sex-specific ultrasonically estimated 
fetal weight curve. This corresponds approximately to the 2.5
th
 percentile. 
Internationally a more common definition is fetal weight less than the 10
th
 percentile.  
 
ACIDEMIA, HYPOXIA AND CELLULAR DAMAGE 
Asphyxia is generally defined as a failure of blood gas exchange, that - if persistent - 
leads to progressive hypoxemia and hypercapnia.
27
 This may however occur transiently 
with no pathological bearing. Therefore, significant fetal asphyxia is defined as a 
failure of blood gas exchange of a duration and degree resulting in tissue oxygen debt, 
with an accumulation of fixed organic acids and a metabolic acidosis.
28, 29
 During the 
1950’s, animal models of fetal monkey and fetal lamb made it possible to 
systematically examine the effects of hypoxia and ischemia on the fetus. Micro-
electrode techniques for blood gas and acid-base analysis were concurrently developed 
to obtain biochemically determined measures of asphyxia in the human fetus. Animal 
studies and studies on acid-base status in the human fetus could confirm that the fetus 
can compensate for an asphyxial event up to a certain threshold and protect the brain 
from damage.
28
 If the event exceeds that threshold, it can cause multi-organ damage 
including the brain, which will account for motor and cognitive deficits. When the 
threshold for compensation has been passed, a progressive metabolic acidemia will 
result in a fall in arterial blood pressure due to decreased cardiac output or reduced 
peripheral resistance. Thus, the explanation for neuronal damage and necrosis has 
several layers; the hypoxemia, the cerebral ischemia due to hypotension, and the 
metabolic acidemia itself. Some neurons die during the asphyxial event (primary 
neuronal necrosis), but many neurons die as a result of processes that take place after 
the event (secondary neuronal necrosis).
30
 Animal studies have shown support of a 
primary and secondary period of neuronal death.
31
  
 
Phases of neuronal death 
During the primary phase; i.e. the hypoxic event itself, there is energy failure and 
development of lactic acidosis resulting in two mechanisms of ion-mediated neuronal 
injury.  There is a disturbance of intracellular chloride ions (Cl
-
) with a sodium ion 
(Na
+
) influx, which leads to intracellular edema, which in turn can lead to lysis of the 
neuronal cell. There is also excessive entry of calcium ions (Ca
2+
) into the cell, which 
initiates a cascade of biochemical events that leads to neuronal death.  
 
 8 
Excitotoxicity is the over-activation of neurotransmitter receptors by excitatory amino 
acids (e.g. glutamate and aspartate) allowing high levels of Ca
2+
 to enter the cells.
32
 If 
the hypoxic event is resolved, a reperfusion starts, during which production of cytotoxic 
free radicals takes place. Following reperfusion and reoxygenation, a secondary phase 
of cell injury occurs, where the mitochondria are as well targets as contributors of 
cytotoxic agents.
33
 Figure 5 schematically shows the phases of different events. 
 
The excess intracellular Ca
2+
 activates nitric oxide synthase (NOS) with subsequent 
production of nitric oxide (NO•). This shifts the electron transport chain to a more 
reduced state, enhancing the formation of superperoxide (•O2
-
) by electron leakage. 
NO• and •O2
- 
reacts to form peroxynitrite (ONOO-), which is a highly reactive and 
toxic agent that modifies mitochondrial proteins by oxidation and/or nitrosylation 
which can lead to depression of mitochondrial respiration, change the membrane 
permeability with eventual swelling and rupture of mitochondrial membrane, and 
increased release of proapoptotic proteins. ONOO- also contributes to production of the 
hydroxyl radical (•OH), which damage proteins and DNA.34 The production and effect 
of these reactive oxidative species (ROS) is called the oxidative stress. 
 
Fig. 5. Phases of neuronal death 
 
XO = xanthine oxidase, nNOS = neuronal nitrite oxide synthase, iNOS = inducible 
nitric oxide synthase 
Copyright © 2008 Karger Publishers, Basel, Switzerland 
 
Most neurons probably survive the asphyxial insult itself, and therefore, great efforts 
have been done investigating effective treatment during the reperfusion phase, where 
hypothermia hitherto is shown to have significant positive impact. There is however a 
tertiary phase during which neuronal necrosis can occur, and the mechanisms of this 
phase are complex.  
There is an inflammatory response to the acute tissue injury, with activation of 
microglia and astrocytes. If there is break-down of the blood-brain barrier, neutrophils 
and macrophages can invade, the formation of scar tissue increases the inflammation 
and cytokine release which leads to increased cell death.
30, 35
 The actual mechanism is 
activation of programmed cell death, why the term apoptosis instead of necrosis often is 
used.  
   9 
Definition of birth asphyxia 
In the late 1990’s, the World Federation of Neurology Group set up a task force for the 
prevention of cerebral palsy and related neurologic disorders. Much effort was put into 
defining an objective template of evidence to identify cases of cerebral palsy where 
neuropathology began or became established around labor and birth.
29
  
In contrast to previous assumptions, several clinical epidemiological studies indicated 
that events leading to cerebral palsy, in most cases occur before onset of labor or in the 
newborn after delivery.
36, 37
 It was stated that the terms “fetal distress” and “birth 
asphyxia” were inappropriate and should not be used clinically. “Fetal distress” should 
be replaced by “non-reassuring fetal status” with a description of the clinical sign or 
test that led to the conclusion, e.g. pathological fetal acidemia with umbilical artery pH 
< 7.00.  
Concerning the term “birth asphyxia”, the timing and onset of asphyxial changes 
should be described when possible, and described as fetal or antenatal if occurring 
before the onset of labor; as intrapartum if occurring between onset of labor and 
complete expulsion of the baby, and neonatal if occurring after birth. Perinatal asphyxia 
can be used when the timing is uncertain.
29
 The task force also suggested not using the 
term “hypoxic ischemic encephalopathy”, but instead “neonatal encephalopathy”, since 
hypoxia and ischemia have often not been proved, and over 75% of neonatal 
encephalopathy have no clinical signs of intrapartum hypoxia.
38-41
  
The criteria suggesting that acute intrapartum hypoxia was the cause of cerebral palsy 
are described below. All three of the essential criteria are necessary before an 
intrapartum hypoxic cause of cerebral palsy can be considered. The four latter criteria 
are individually only weakly associated with an acute intrapartum hypoxic event, since 
all of them except criterion 4 may be caused by other factors, e.g. infection. If some of 
criteria 4-8 are missing, the timing of onset becomes in doubt, and if they are 
contradictory, e.g. a normal Apgar score at five minutes, they weigh against a serious 
acute event.
29
 
 
Table 1. Criteria to define an acute intrapartum hypoxic event 
 
Essential criteria 1 Evidence of a metabolic acidosis in intrapartum fetal, 
umbilical arterial cord, or very early neonatal blood samples 
(pH < 7.00 and BD ≥ 12 mmol/l) 
2 Early onset of severe or moderate neonatal encephalopathy 
in infants of ≥ 34 weeks’ gestation 
3 Cerebral palsy of the spastic quadriplegic or dyskinetic type 
Criteria that together 
suggest an 
intrapartum timing 
but by themselves 
are non-specific 
4 A sentinel (signal) hypoxic event occurring immediately 
before or during labor 
5 A sudden, rapid, and sustained deterioration of FHR pattern 
usually after the hypoxic sentinel event where the pattern 
was previously normal 
6 Apgar scores of 0-6 for longer than 5 minutes 
7 Early evidence of multisystem involvement 
8 Early imaging evidence of acute cerebral abnormality 
MacLennan A. BMJ. 1999 Oct.16;319(7216):1054-9.  FHR = fetal heart rate 
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Neonatal outcome measures 
In developed countries, neonatal deaths and cerebral palsy are rare with reported 
neonatal mortality rates of 1.2 per 1000 live births in Sweden, and frequencies of 
cerebral palsy approximately 2 per 1000 live births,
42, 43
 and if children born at term 
(>36 weeks of gestation) are considered, the rates are even lower. Thus, the effects of 
surveillance methods and interventions on such rare endpoints are difficult to study, 
and many studies use surrogate outcomes such as hypoxic neonatal encephalopathy, 
low Apgar score and umbilical acid base measures to evaluate associations and risk 
factors.  
 
The association between acidemia at delivery and neonatal complications has been 
demonstrated, and has shown a significant correlation between severe acidosis, i.e. 
umbilical artery pH (UA-pH) < 7.00 and occurrence of newborn complications.
44, 45
 In 
a prospective population based study of newborns with acidemia defined as pH 7.05 at 
birth (the 1
st
 percentile of the source population) there was an association with neonatal 
encephalopathy and speech problems at four years follow up.
46
 Other studies have 
demonstrated that the majority of moderate and severe neonatal encephalopathy and 
other organ system complications occurred in newborns with umbilical BD above the 
threshold of 12 mmol/L,
21, 47
 as well as a significant increase in motor and cognitive 
development deficits at one year of age.
48, 49 
 
 
CARDIOTOCOGRAPHY 
Fetal surveillance during labor started with auscultation of the fetal heart during the 
1900
th
 century. Auscultation of the fetal heart rate and inspection of the amniotic fluid 
were for many years the only ways to assess fetal status during labor. The technique of 
electronic fetal monitoring (EFM) developed during the 1950’s by the work of Hon and 
coworkers and Hammacher.
50, 51
 The name cardiotocography (CTG) originates from the 
Greek words “kardia” (heart), “tocos” (childbirth) and “graphe” (writing).  
 
Antepartum and intrapartum before rupture of membranes, only external monitoring 
can be used. A Doppler signal is sent toward the fetal heart, and through the Doppler 
effect, i.e. the changed frequency of a wave movement reflected back when meeting an 
object in movement, this change in the Doppler signal is recalculated to beats per 
minute (bpm) by the CTG machine. 
Intrapartum after rupture of membranes and when the cervix is dilated at least 1 cm, 
internal monitoring is possible, and the fetal heart rate is then directly registered by a 
scalp electrode attached to the presenting fetal part. Internal monitoring is less sensitive 
to errors, but also invasive and infectious diseases as Hepatitis B, HIV and active 
genital herpes are contraindications as well as possibility of inherited coagulopathy in 
the fetus. Internal monitoring also restrains the woman from moving freely during 
labour. There should always be a clear indication for application of a scalp electrode, 
and as long as there is acceptable quality of external monitoring this is sufficient. 
CTG was rapidly introduced into clinical practice with the hope to significantly reduce 
perinatal mortality and morbidity, in particular the frequency of cerebral palsy. Several 
uncontrolled studies had suggested that routine EFM was associated with a reduction in 
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intrapartum stillbirths and neonatal deaths. Parallel to the clinical use, animal and 
clinical studies were performed to evaluate the significance of the new information the 
technique gave besides the actual heart rate. 
 
Randomized controlled trials were performed during the 1970’s and 1980’s, comparing 
CTG with intermittent auscultation. The Dublin trial with approximately 13000 
participants could not show a reduction in cerebral palsy or neonatal mortality, but the 
rates of seizures and persistent neurologic signs in the neonatal period were halved in 
the EFM group compared with the group with intermittent auscultation. Follow-up at 
one year of age in babies with neonatal seizures revealed no difference between the 
groups,
52
 and neither did a four-year follow-up.
53
 Three children in each group that had 
survived neonatal seizures had been diagnosed with cerebral palsy, and the majority of 
children with cerebral palsy in the total study population had not shown clinical signs 
suggestive of intrapartum asphyxia.
53
 One possible limitation of the Dublin trial was 
that cases with meconium-stained amniotic fluid, preterm deliveries and women with 
rapid course of labor and delivery within one hour from arrival in the labor ward were 
excluded. Through this exclusion of high-risk labors, 56 of the 82 neonatal deaths were 
excluded, thus minimizing the chance of showing a reduction in mortality. There was 
only a small difference in rates of cesarean deliveries associated with the two policies.  
 
The Athens study was smaller with 1400 participants, but did not exclude women with 
risk factors as the Dublin trial. There was also a higher perinatal mortality rate in the 
background population in Greece, compared with the one in Ireland, and the reduction 
in perinatal mortality was significant and so large, that the trial was discontinued by 
ethical reasons.
54
 A meta-analysis of the thirteen existing randomized studies 
comparing CTG with intermittent auscultation states that CTG is associated with a 
halving of neonatal seizures and a significant increase in cesarean deliveries (RR 1.63), 
but no differences in cerebral palsy rate or overall perinatal death rate.
1
 Vintzileos et al 
published a meta-analysis of nine of the randomized trials, with exclusion of trials with 
intermittent EFM and trials comparing selective versus universal EFM. They found a 
significant reduction in perinatal mortality if only deaths attributed to fetal hypoxia 
were included.
55
 They also excluded deaths that could not be attributed to the method 
of monitoring such as cord prolapse, congenital heart disease and hemorrhage. This 
way of analyzing the data has been criticized, but the authors argued that it is not 
reasonable to expect CTG to predict or to prevent other causes of perinatal death e.g. 
shoulder dystocia, placental abruption, umbilical cord prolapse or uterine rupture.   
 
Terminology 
The five parameters to assess in CTG are baseline heart frequency, variability, 
accelerations, decelerations and uterine contractions. During the years since the 
introduction of CTG, numerous different definitions and guidelines have appeared.
56-64
 
After almost 30 years, the guidelines of the International Federation of Gynecology and 
Obstetrics (FIGO) from 1987 still remains the only broad international consensus 
document on EFM, and many national guidelines refer to them (Table 2). However, the 
shortcomings are substantial with lack of objective definitions of some fetal heart rate 
(FHR) features, and others only vaguely defined.  
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Table 2. Comparison of FHR definitions in guidelines of FIGO,
56
 SFOG,
64
 
RCOG/NICE,
57, 65
 ACOG/NICHHD/SMFM,
59, 60
 SOGC
61
 and RANZCOG
58
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*Hypothezised to be a transcription error, since 10 sec is very difficult to discriminate with the naked eye. 
More logical would be 10 bpm and 15 sec, to include the flaccid but potentially alarming late 
decelerations.
65
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Table. 3. CTG classification systems in different guidelines 
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Classification systems 
As shown above in Figure 3, many countries have adopted some kind of classification 
system for CTG patterns, often quite similar to the FIGO document from 1987. Most 
guidelines have a three-tier classification, but with some differences in divisions and 
nomenclatures, as shown in Table 3. All classifications are, in similarity with the FIGO 
classification, consensus documents, and not evidence-based. Several concerns have 
been brought up in recent years, regarding the effectiveness of the classification 
systems.
62, 65, 66
 Di Tommaso et al. compared five of the classification systems, with the 
finding that all classification system analyzed had a low discriminative capacity when 
predicting UA-pH ≤ 7.15, and that a common problem is that the vast majority of CTG 
traces end up in the intermediate or “suspicious group.66 
 
CTG findings and correlation to fetal status 
 
Baseline FHR 
The baseline frequency had been recorded by auscultation long before the introduction 
of cardiotocography. Early studies by Hon revealed a mean of 140 bpm, and he stated 
that the majority of FHR recordings to the date of the study had been within the range 
120-160.
67
 As shown above, several consensus guidelines has a wider range of 
normality, between 110 and 160 bpm,
57-60, 68
 and the FIGO consensus document as well 
as the current Swedish guidelines use the range of 110-150 bpm as normal interval. In a 
recent study, Pildner von Steinburg et al. stated after a thoroughgoing literature search 
that the range of normality for baseline FHR was neither international consensus nor 
evidence-based. They computed the baselines from nearly 79,000 consecutive CTG 
tracings, both antenatal and intrapartum, ranging from gestational week 24 to term, 
which revealed that the range of 110-150 represented the approximately 0.6
th
 to 86
th
 
percentile in that study, and that the range 110-160 represented the 0.6
th
 to 96
th
 
percentile.
69
 The authors mean that the reason for FIGO’s lowering the former range 
from 120-160 to 110-150 at the consensus meeting 1985, was motivated by reports of a 
high prevalence of abnormal fetal scalp blood analyses in cases with a baseline in the 
higher range.
70
 
71
 
The baseline heart rate is dependent on a complex interaction between the autonomic 
nervous system, humoral and metabolic conditions in the fetal heart. Due to successive 
maturation of the central nervous system during pregnancy, the parasympathetic system 
becomes more and more dominating, and therefore there is a small but notable decrease 
in fetal heart rate throughout pregnancy.
56
  
 
Tachycardia can arise from maternal fever, increased sympathetic tone in either fetus or 
mother, anemia in mother or fetus, thyroid overproduction and fetal arrhythmia, but 
most important tachycardia can be an early sign of fetal hypoxia. As previously 
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mentioned, the cardiac output works near its limit already under normal circumstances 
and cannot be increased, and thus, the only way for the fetus to compensate for 
decreased pO2 in the blood is to increase the heart rate.
9
 
Bradycardia can start as a vagal reflex e.g. during rapid progression of labor with 
compression of the fetal head and in these reflex situations, it is not a sign of, but can 
rapidly lead to hypoxia. In situations of maternal hypotension as in compression of 
vena cava, the fetal bradycardia is mediated by baroreceptors, and is quickly restored 
with change of maternal position. In cases with complete cessation of umbilical 
circulation as in cord prolapse or placental abruption, the bradycardia is due to hypoxic 
depression of the myocardium.
72
 A rare cause of marked bradycardia without hypoxia 
is fetal arrhythmia, i.e. atrioventricular block. 
  
Variability 
 
 
The fetal heart rate is normally varying, both from beat to beat, and over longer periods, 
i.e. minutes. The former, i.e. the short term variation, is the time difference between 
every two beats; in most cases impossible for visual recognition, and the latter - called 
the long term variability, is what we assess in a usual non-computerized CTG 
interpretation. Animal studies have shown this variation to be dependent upon the 
constant balance between the sympathetic and parasympathetic nervous systems, but 
also upon non-neuronal components.
73
 Intermittent low variability normally occurs 
during fetal sleep, in cycles lasting up to 45 minutes near term.
74
  
A fixed FHR without variability is typically seen in anencephalic fetuses.
75
 Decreased 
variability was associated with increased risk of cerebral palsy in a case control study 
by Nelson et al., and the risk persisted after adjustment for known risk factors for 
cerebral palsy (e.g. preterm delivery, breech presentation and maternal infection) with 
an OR for cerebral palsy of 2.7. However, the false-positive rate was 99.8%.
76
 Williams 
et al. concluded that minimal or absent variability for > 1 hour was the most significant 
fetal heart rate parameter to predict development of umbilical artery acidemia in a 
cohort study of nearly 500 fetuses.
77
 The proportions of reduced vs. absent variability 
was however not stated.  
 
Accelerations 
Accelerations are physiologic responses to fetal movements, but can also be triggered 
by uterine activity.
78
 Other triggers are manipulations of uterus and fetus, e.g. reaction 
to painful events as application of scalp electrode or FBS. Accelerations are a reliable 
sign that the cardiovascular unit, the autonomic nervous system and the central nervous 
system are intact and well-functioning. Although accelerations are reassuring for a well 
oxygenated fetus, the opposite cannot be said. Absence of accelerations is common 
during labour, and gives rise to concern about the well-being of the fetus. Different 
stimulation tests can then be performed, and provoked accelerations through scalp 
stimulation by Allis clamp, FBS or digitally as well as vibroacoustic stimulation are 
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reported as reassuring signs of a non-acidemic fetus.
79
 Clark et al. reported that none 
out of 169 cases with an acceleration as response to FBS had acidemia, but 19 out of 31 
that did not react with an acceleration were acidemic in scalp blood. Several other 
studies have repeated this finding. 
 
Decelerations 
 
 
While baseline FHR, variability and accelerations can be regarded as signs of the fetal 
state, decelerations can be looked upon as what the fetus is exposed to e.g. contractions, 
pressure towards the fetal head and orbitae, a suboptimal function of the placenta or 
compression of the umbilical cord. Very often the eyes of doctors as well as midwives 
moves directly to focus on the decelerations when assessing a CTG trace, but more 
important than the decelerations are the baseline and variability after the end of 
decelerations. If baseline and variability are normal, the fetus does not have to 
compensate for the heartbeats “lost” during the contraction. 
Decelerations are the parameter with the most varying terminology between different 
countries and guidelines, there have been numerous changes over the years, and there 
are controversies regarding definitions and subdivisions.
80, 81
  
This is also the CTG parameter that varies most between different CTG interpreters i.e. 
has the largest inter-observer variability.
82
 
With this in mind, it is however important to understand the pathophysiological 
mechanisms behind FHR decelerations. Several animal and human studies have in 
detail investigated the different origins of decelerations with a uniform and a variable 
shape respectively. During the first decade of CTG monitoring in clinical practice, Hon 
and Quilligan identified three types of decelerations; early, late and variable type, and 
reported that late decelerations and variable decelerations that were profound and of 
long duration were associated with fetal depression.
83
 Kubli reported that late and 
severe variable decelerations were associated with fetal scalp blood acidemia.
71
 
 
Late decelerations 
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Myers demonstrated in an animal study that monkey fetuses exposed to partial hypoxia 
had episodes of fetal bradycardia and hypotension following uterine contractions, 
called Type II dips, which corresponds to the name (uniform) late decelerations used 
currently.
84
 In the same experiment he also demonstrated the various types of cerebral 
damage after different degrees of hypoxia. He could report that late decelerations 
invariably appear when fetal arterial pH drops to levels at or below 7.10-7.15, and a 
concurrent pO2 drop. He stated that the decelerations regularly follow uterine 
contractions by 20 to 30 seconds, and that the delay from start of contraction to the 
beginning of the induced deceleration reflects the time required for depletion of the O2 
stored in the intervillous space in the placenta and the transport of the O2-deprived 
blood from the placenta to the fetal myocardium. Late decelerations can be discrete in 
both duration and amplitude even in a severely deteriorated fetal status.  
In a sheep model by Parer et al., late decelerations were provoked by abrupt decrease in 
uterine blood flow. In sheep fetuses that were normoxic at beginning, the late 
decelerations were abolished by compete vagal blockade. In sheep fetuses that already 
had been exposed to chronic hypoxia the late decelerations could not be abolished by 
pretreatment with atropine.
85
 They stated that late decelerations had two possible 
reasons. The reflex type provoked in normoxic fetuses was vagal mediated and due to 
chemoreceptor rather than baroreceptor activity, and the decelerations appearing in 
fetuses already hypoxic when exposed to impaired oxygen supply were due to direct 
hypoxic depression of the myocardium.  
Several clinical studies have reported a significant correlation between late 
decelerations and neonatal morbidity.
86-88
 Repetitive late decelerations gave an OR of 
3.7 for cerebral palsy in a case-control study of 78 children with a cerebral palsy 
diagnose at 3 years of age.
76
 In a case-control study of 125 preterm newborns with 
ultrasound-verified white matter injury, late decelerations were associated with a 
decreasing pH in umbilical artery, but there was no significant difference in frequency 
of acidemia between cases and controls.
88
 
 
Variable decelerations 
 
 
As mentioned above, decelerations have as well the most varying terminology and 
definition between different guidelines, as the largest inter-interpreter variation. Among 
the decelerations, the variable type is most unclear when it comes to terminology. 
Different authors and guidelines use the terms simple, mild, typical or uncomplicated 
for variable decelerations with duration less than 60 seconds, but some also demands 
pre- and post-accelerations for the definition, and some guidelines divides the 
uncomplicated further regarding duration more or less than 30 seconds and amplitude 
more or less than 60 bpm. All guidelines are fairly consistent in definition of, but not 
name of the more serious type of variable deceleration that can be indicative of fetal 
hypoxia. All guidelines demand duration of more than 60 seconds for the definition of a 
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severe/atypical/complicated variable deceleration. As shown in Table 2, some 
guidelines also define other features of the CTG trace such as the baseline and 
variability, for the definition of a complicated variable deceleration. 
 
Numerous studies on the sheep model have shown that a sudden and total occlusion of 
the umbilical vessels is associated with an abrupt fall in fetal heart frequency, and that 
the frequency returns to baseline when the umbilical circulation is restored.
89, 90
 In 
experiments with occlusion 1:5 and 1:2.5 minutes, they could demonstrate an increased 
fetal mean arterial pressure during occlusions, and a reflex periodic bradycardia. Thus, 
these decelerations were explained by a baroreceptor response to the increased fetal 
blood pressure during umbilical occlusions. A review of the physiologic explanations to 
decelerations stresses however that the initial reflex triggering decelerations is 
chemoreceptor mediated.
91
  
Clinical studies have reported an association to neonatal depression and birth acidemia 
if severe variable decelerations are present together with tachycardia or reduced / 
minimal variability. 
92, 93
 
In a large study by Hamilton et al., CTG tracings from the last 4 hours from 3 320 
babies with umbilical BDblood < 8 mmol/L and from 316 babies with umbilical BDblood 
> 12 mmol/L were analyzed with computerized pattern recognition. The aim was to 
determine the ability of 8 subtypes of variable decelerations, defined by size and shape, 
to discriminate between normal umbilical blood gases and those with metabolic 
acidemia and neonatal encephalopathy. Of all features commonly used as grading of 
severity of the variable decelerations, e.g. lower baseline after deceleration, prolonged 
duration, loss of internal variability, biphasic shape, prolonged secondary rise, loss of 
pre- and post-acceleration, slow return to baseline; only 3 subtypes showed significant 
discrimination: those with prolonged duration, loss of internal variability or with at 
least two of the “sixties” criteria (depth ≥ 60 bpm, lowest value ≤ 60 bpm, duration ≥ 
60 seconds). All other subtypes were no better than chance.
81
 However, not even the 3 
subtypes that were significantly associated with birth acidemia had an impressive 
predictive ability, with values ranging between 0.57 and 0.61 in the area under the 
receiver-operating characteristic curve. 
 
Early decelerations 
Early decelerations are one of the three types of decelerations firstly described by Hon 
et al. They are commonly explained as caused by compression towards the fetal head 
with resulting changes in cerebral blood flow.
94, 95
 A vagal reflex via medullary centres 
reduces FHR, and a deceleration with a smooth start and end typically mirrors the 
contraction. They are generally in all guidelines considered benign and seldom 
associated with fetal hypoxia or acidemia. There are however diverging opinions 
regarding origin as well as interpretation.
80
 In one review of decelerations, it is 
speculated that the discrepancy between opinions about how frequent early 
decelerations appear, is explained by which paper speed is used. The authors describe 
that the early decelerations originally described by Hon and Quilligan with a paper 
speed of 3 cm/min look like mild variable decelerations at 1 cm/min.
91
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Uterine contractions 
 
 
External monitoring mainly gives information on the frequency of contractions. As a 
tocodynamometer measures the increase and decrease in myometrium tension through 
the abdominal wall, this is affected by placement of the probe, the tightness of the 
supporting elastic band, and abdominal adiposity. For information of duration of 
contraction, abdominal palpation can be used, but the only way to monitor the intensity 
and basal uterine tonus is internal monitoring. Although of theoretical importance, in a 
randomized trial, the use of internal monitoring of uterine contractions could not be 
shown to be beneficial, neither for the woman nor the fetus.
96
 However, internal 
monitoring of contractions can be necessary if a satisfactory external recording cannot 
be achieved due to maternal adiposity or other reasons, especially in augmented labor. 
 
Inter-observer variability 
One of the problems with CTG is that interpretation of patterns differs between 
observers. Early studies during the 1980s revealed a uniform interpretation in 22-29% 
of cases.
97, 98
 Studies during the 1990s and more recent studies used the Kappa statistics 
and Proportion of agreement calculations to examine intra-, and inter-observer 
variability in CTG interpretation. There are comparisons of as well interpretations of 
the different parameters, as interpretations of the classification into different tier 
systems. A Kappa value of > 0.75 is generally considered excellent, 0.4-0.75 fair to 
good, and < 0.4 poor. Kappa for classification varied in different studies between 0.48 
and 0.77.
99-101
 In a study by Bernardes et al., Kappa was better for baseline and 
accelerations (0.51 and 0.52 resp.) than for variability (0.35), and worse for 
decelerations (0.21-23 for early and late decelerations, and merely 0.05 for variable 
decelerations).
82
 These unsatisfactory results have yielded discussions and debates 
concerning the usefulness of CTG, as well as educational programs with the aim to 
reach a more uniform interpretation. In a recent study from 2013 using the definitions 
by National Institute of Child and Health and Human Development (NICHHD), the 
Kappa values were remarkably higher for all parameters (K 0.97 for baseline, 0.8 for 
variability, 0.62 for accelerations, 0.8 for late decelerations and 0.64 for variable 
decelerations). They were consistent throughout the observers with varying degrees of 
experience.
102
 The authors suggest that the uniform training and education in addition 
to standardized definitions and interpretation were of significant value. 
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FETAL SCALP BLOOD SAMPLING 
Normal range of fetal pH, BD and lactate concentration 
The method of FBS was developed quite shortly after the introduction of CTG. Saling 
et al did the first studies investigating the normal range of pH-value of fetal blood. 
Through FBSs during labor of 306 fetuses who were “very vigorous at birth”, they set a 
mean value of fetal scalp pH during first stage of labor between 7.333 and 7.338. They 
noticed that pH values were quite stable during first stage of labor, but there was a 
pronounced fall late in second stage to pH values between mean value of umbilical 
artery (7.27) and umbilical vein (7.33). Since scalp blood is capillary blood, it is logical 
to have a pH value between that of oxygenated umbilical vein blood coming from the 
placenta, with lower pCO2 and thereby higher pH, and deoxygenated umbilical artery 
blood with higher pCO2, and lower pH having circulated through fetal tissues.   
Lower limit of normal range during labor was set as the mean minus 2 SD’s which was 
between 7.227 and 7.196.  For clinical use, they suggested that fetal values between 
7.20 and 7.24 should be considered as pre-pathologic, and values below 7.20 as 
pathologic or “acidemic”.103 Mean and normal range of fetal pH have been confirmed 
in other studies.
104
  
 
Although Saling et al. in the initial studies took into account the influence of pCO2, and 
calculated pH values equilibrated to normal pCO2, with the intention to adjust for the 
respiratory component, this never became clinical practice. pH analysis of fetal scalp 
blood has been regarded as gold standard in FBS, but has several disadvantages. Since 
it requires a considerable amount of blood, sampling and/or analysis failure due to air 
contamination has been reported in 11-21% of cases.
105, 106
 It does not discriminate 
between respiratory and metabolic acidemia, where the former is shown to be of no 
harm to the fetus.
21
  
The main purpose of FBS is to identify fetuses with developing anaerobic metabolism 
and thus metabolic acidemia, when the CTG tracing is non-reassuring, with the aim to 
deliver the baby at “the window of opportunity” i.e. before any organ damage is 
established. Secondly, FBS can be used to rule out metabolic acidemia in cases with a 
falsely positive CTG tracing, to reduce unnecessary interventions. Since the end 
products of anaerobic metabolism are lactate
-
 and H
+
, lactate analysis of fetal scalp 
blood was an attractive alternative to pH measurements, and during the 1970’s, 1980’s 
and 1990’s, lactate analysis of umbilical and fetal scalp blood was investigated.19, 104, 
107-110
  
Lactate concentrations were calculated in two different low risk populations of women 
with means 1.2-1.7 mmol/l in whole blood.
110, 111
 These values were analyzed with a 
prototype of the currently used meter, and correspond to 1.6-2.3 when analyzing with 
Lactate Pro™ (Figure 6). Lactate concentrations have been shown to be stable 
throughout first stage and through passive part of second stage, only increasing during 
the active phase of second stage of labor.
25
 
 
There have been few studies on BD values in fetal scalp blood. Umbilical BD measures 
have been evaluated, and Helwig et al. reported a mean umbilical BDblood of 4 mmol/L 
from a population of 16000 newborns.
112
 The 2 SDs of 11 mmol/L corresponded well 
with earlier findings by Low.
113
   
   23 
Fig. 6. Portable lactate meter for bedside use. 
 
 
 
 
Correlations between fetal lactate, acid base status 
 and neonatal outcome 
Animal studies with experimental hypoxia have shown that lactate concentration in the 
heart and brain correlates to lactate concentration in umbilical arterial blood,
114
 as well 
as with subcutaneous lactate concentration.
115, 116
 
Lactate in fetal scalp blood is shown to have a good correlation with as well fetal scalp 
blood pH as fetal scalp blood BD,
4, 117
 and also with umbilical pH, BE and lactate.
4, 117, 
118
  
Umbilical lactate is in several studies shown to correlate well with umbilical pH, with r 
ranging from - 0.38,
119
 to -0.69.
117, 120
 The study by Linet showed an even higher 
correlation between lactate and BD in umbilical artery blood, with r = 0.84, and r
2 
= 
0.48. This has been confirmed in a large Danish study of umbilical blood samples from 
2554 deliveries.
121
 They found similar correlations between lactate and pH (r = - 0.73), 
lactate and SBE (r = - 0.76) and lactate and ABE (r = -0.83).  
 
There are several studies on the correlation between BD and neonatal outcome, 
revealing a threshold for significant metabolic acidemia at a BD between 12 and 16 
mmol/L.
122
 Animal studies on the lamb model showed that significant metabolic 
acidosis is associated with seizures, and clinical studies have described an association 
between severe acidemia and multi-organ dysfunction in the newborn.
45
 
Early neonatal lactate correlated significantly with umbilical artery BD (r
2 
= 0.51), 
when measured in radial artery blood within 30 min. Lactate concentration lower than 5 
mmol/L and/or BD lower than 10 mEq/l were not followed by neurological 
complications. A lactate concentration greater than 9 mmol/L was associated with 
moderate or severe encephalopathy with a sensitivity of 84% and a specificity of 
67%.
123
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Predictive and preventive lactate values 
Several studies have investigated the predictive ability of lactate.
4, 118, 124, 125
 In a 
retrospective study by Kruger et al., the fetal scalp lactate values with maximum 
sensitivity and specificity for moderate to severe hypoxic ischemic encephalopathy 
(HIE) was 6.5 mmol/L, and for Apgar score < 4 at 5 minutes 6.0. Lactate with the 
highest accuracy for UA-pH < 7.00 was 5.1 mmol/L.
124
 In a prospective cohort study 
by Ramanah, a scalp lactate cutoff value of 5 mmol/L was the most predictive for 
neonatal acidosis.
125
 Heinis et al. reported from a retrospective observational study that 
fetal scalp lactate < 5.4 mmol/L indicated reassuring fetal status, whereas lactate ≥6.6 
mmol/L indicated metabolic acidemia in umbilical artery. 
Since the aim is to prevent and not predict birth acidemia and neonatal complications, 
the cutoff must be set below predictive values, and in Sweden the cutoff used for 
recommendation of intervention is 4.8 mmol/L, which was the 75
th
 percentile in the 
study by Kruger.
124
 This corresponded well with the formerly used pH cutoff for fetal 
acidemia at 7.20, and thus, indication that intervention rates would not increase by the 
use of lactate analysis at FBS. 
 
Two randomized controlled trials (RCTs) have compared lactate analysis with pH 
analysis of fetal scalp blood, with similar advantages of significant less failure rate (1.2-
1.3 % vs 10.4-19.6 %), but no differences in neonatal outcome or intervention rate.
105, 
126
 Neonatal outcome measures included low Apgar score at 5 minutes, admission to 
neonatal intensive care unit, low UA-pH, high BD values or metabolic acidemia in 
umbilical artery. Comparisons were done overall as well as between those where FBS 
had been performed within 60 minutes prior to delivery. 
 
The lactate concentration is stable throughout first stage of labour,
110
 but increases in 
both mother and fetus during the active part of second stage of labour. During active 
pushing, lactate increases by 1 mmol/L per 30 minutes in the fetus, and by 2 mmol/L in 
the mother.
127
 The increasing arterial-venous difference in lactate concentration in 
acidemic fetuses compared to non-acidemic fetuses suggests fetal origin of the 
lactacidemia.
24
 Since there is a physiological increase in all fetuses, another cut-off 
value would possibly be adequate for lactate measures during active second stage. 
However, a limit that must be safe for all fetuses, would be difficult to set, and 
additionally, adding separate recommendations for different phases of labor would 
make the method less feasible in clinical practice.
127
 
 
 
The usefulness of FBS as an adjunct to CTG monitoring 
Critics of the use of FBS argue that there is no shown benefit of FBS as an adjunct to 
intrapartum CTG, with reference to the meta-analysis of EFM.
1
 The comparison was 
however between RCTs with access to FBS in all arms, and RCTs without the adjunct 
of FBS, and the different RCTs varied largely in as well inclusion criteria, routines of 
intrapartum care, and levels of background risks in the study populations. The only 
study that randomized to CTG with or without FBS was the Denver study with 690 
patients i.e. 230 in each arm. They reported a cesarean rate of 18 % in the CTG only 
group, and 11 % in the CTG + FBS group, and cesarean for fetal distress 7 % and 3 %, 
respectively. The differences were not significant; it is possible that the study was 
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underpowered and would have needed some 350 cases in each arm for statistical 
significance of the reported magnitude of differences in proportions. 
 
When lactate analysis is used in FBS, the measured entity is the concentration of lactate 
ions and not pH and thus, the proper term to use would be lactemia rather than 
acidemia or lactacidemia. As explained above, the main reason for increased lactate 
production is anaerobic metabolism with lactate as the end product, and development of 
metabolic acidemia. Therefore, these terms will be used equally in this thesis.  
 
Theoretically, there can be situations with increased lactate concentration and normal 
pH, and thus, lactemia without acidemia. Initially during incipient anaerobic 
metabolism, hydrogen ions produced parallel with lactate can be buffered by other 
buffer bases than HCO3
-
 and therefore pH initially can stay unaltered for a short period. 
Engidawork et al. showed in an animal model, that subcutaneous lactate correlated well 
with intracerebral levels of lactate, pyruvate and pH. Under hypoxic conditions, the 
increase in subcutaneous lactate concentration preceded the pH decrease and lactate 
increase in the brain tissue.
115
 This supports the view of lactate as an early marker in the 
hypoxic process.  
The theoretical rationale between pH and lactate concentration is illustrated below in 
Figure 7. Both pH and lactate will identify a metabolic acidemia. A respiratory 
acidemia diagnosed with pH will have a normal result if lactate concentration is 
determined, and correspondingly, cases with high lactate without acidemia will not be 
discovered by pH. During labor, with successively increasing frequency and power of 
contractions and concomitant intermittent reduction in oxygen supply, it is unlikely that 
incipient anaerobic metabolism would regress, and in accordance with the findings of 
Engidawork et al., lactemia would not be an innocent situation of a false positive test, 
but rather an earlier stage than lactacidemia in the hypoxic process.
128
 
 
 
Fig. 7. Correlation between pH and lactate and illustration of groups that will be 
considered abnormal dependent on analysis type. 
 
Reprinted from Best Practice & Research Clinical Obstetrics and Gynaecology 
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AIMS 
The general aim of this thesis was to increase the knowledge about fetal lactate 
concentration and correlation to as well CTG patterns as to neonatal outcome, and to 
elucidate several aspects of lactate production as a fetal response to intrapartum 
hypoxia. 
 
The specific aims of the individual studies were: 
 
 To analyse short-term neonatal outcome and sampling to delivery interval in 
cases with severe intrapartum acidemia. (Study I) 
 
 To compare the fetal response to hypoxia between growth-restricted fetuses 
and appropriately grown fetuses in terms of lactate production. (Study II) 
 
 To study the association between different CTG patterns and intrapartum fetal 
lactacidemia. (Study III) 
 
 To investigate if repeat (≥3) FBS is associated with increased risk of fetal 
acidemia, operative interventions and worse neonatal outcome than 1-2 FBS 
during labor. (Study IV) 
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MATERIALS AND METHODS 
STUDY POPULATION 
The present thesis is based on two different cohorts of women. All subjects were 
women who underwent fetal blood sampling during labor. They presented a CTG 
pattern that was assessed as non-reassuring or pathological and considered an 
indication for FBS by the clinician in charge. 
  
Population in studies I and II 
Subjects in study I and II were women included in a former multicenter RCT, 
performed in ten obstetric units in Sweden. The women had given informed consent 
either at antenatal clinics or at admission to the labor ward. They had a singleton 
pregnancy of ≥34 weeks with cephalic presentation. When intrapartum CTG tracing 
was non-reassuring and the attending doctor found indication for FBS, they were 
randomized to FBS with pH-analysis, or FBS with lactate analysis. Study I included all 
2,992 women that had been randomized to either pH-analysis or lactate analysis. Due to 
sampling failure and several other reasons for no collection of blood, such as rapid 
delivery, reassuring CTG and withdrawn consent, there were 1008 women with 
available data in the pH group and 1354 women in the lactate group of the 1,496 
randomized women to each arm. Subjects in study II were the women randomized to 
FBS with lactate analysis. Background data on the study population is shown in Table 
4. 
 
Table 4. Characteristics of study population in studies I and II. (medians [range], 
numbers [%]) 
  Population Study I 
(n=2992) 
Population Study II 
(n=1354) 
Maternal age 
(years) 
 
33 (19-49) 31 (18-46) 
Gestational age 
(weeks
days
) 
 
40
3 
(34
0
-44
2
) 40
3 
(34
0
-43
6
) 
Parity Nulliparous 2334 (78.0) 1065 (78.7) 
Multiparous 658 (22.0) 289 (21.3) 
Mode of delivery VE/Forceps 786 (26.3) 342 (25.3) 
Caesarean delivery 867 (29.0) 414 (30.6) 
Birth weight (g)  3565 (1590-6110) 3570 (1860-6110) 
VE=vacuum extraction 
 
Population in studies III and IV 
Studies III and IV were performed in the labor ward at Karolinska University Hospital, 
Solna, Sweden, with approximately 4500 annual deliveries during the study period. The 
department is a primary obstetric service center for Stockholm County and a tertiary 
referral center. The study population consisted of women with a singleton pregnancy of 
≥34 weeks with cephalic presentation, and indication for FBS during labor according to 
the clinician in charge. Characteristics of the study population are shown in Table 5. 
Women gave informed consent prior to sampling. After an interim analysis which 
revealed a probability of substantial amount of missing cases, ethic approval was 
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obtained for search in medical records to include all cases with FBS. During the study 
period there were 1070 women who underwent FBS and met the inclusion criteria. 
 
Table 5. Characteristics of study population in studies III and IV. 
 
 
Total population 
N=1070 
Maternal age (years)  
≤24 137 (12.8) 
25-35 725 (67.8) 
≥36 208 (19.4) 
Nulliparous 772 (72.1) 
Previous cesarean delivery 109 (10.2) 
Gestational age (weeks
days
)   
34
0
-36
6
 36 (3.4) 
37
0
-40
6
 724 (67.7) 
≥410 310 (29.0) 
Induction of labor 380 (35.5) 
Birth weight group  
SGA 48 (4.5) 
AGA 984 (92.5) 
LGA 32 (3.0) 
Birth weight (grams)  
<2500 30 (2.8) 
2500-3999 858 (80.2) 
4000-4500 149 (13.9) 
>4500 29 (2.7) 
SGA= small for gestational age 
AGA=appropriate for gestational age  
LGA= large for gestational age 
 
STUDY DESIGN 
Study I is a secondary analysis of all participants in an earlier performed RCT. 
Intrapartum acidemia was defined as fetal scalp blood lactate concentration above the 
95
th
 percentile in the arm with lactate analysis, and fetal scalp blood pH below the 5
th
 
percentile in the group with pH analysis. Outcome measures were UA-pH < 7.00, 
Apgar < 7 at 5 minutes, hypoxic ischemic encephalopathy and time interval from FBS 
to delivery. 
Study II is a secondary analysis of the women in the lactate analysis group in the earlier 
performed RCT. Fetuses were divided according to birth weight group, and outcome 
measures were lactate concentrations at FBS during labor. 
Study III is a prospective observational cohort study, where CTG tracings prior to FBSs 
were visually interpreted by a senior obstetrician. The CTG reviewer was blinded to the 
analysis result of FBS, and the CTG abnormalities were correlated to median lactate 
concentration and frequency of acidemia at FBS, which was the outcome measure. 
Study IV is a prospective cohort study from the same study population as Study III. 
Women were divided into two groups according to number of FBSs during labor; 
women undergoing 1-2 samplings and women undergoing ≥ 3 samplings. Outcome 
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measures were Apgar score < 7 at 5 minutes, metabolic acidemia (pH < 7.05 and BD > 
12 mmol/L) in umbilical artery and frequency of cesarean delivery. 
 
ELECTRONIC FETAL MONITORING 
Intrapartum fetal surveillance followed Swedish guidelines.
129
 
All women underwent a CTG monitoring at admission to the labour ward, and if they 
were considered at low risk, they had intermittent CTG monitoring every 2 hours with 
auscultation of fetal heart rate in between. If they were considered at high risk (e.g. 
preeclampsia, hypertension, IUGR), if they had oxytocin augmentation or epidural 
analgesia they had continuous CTG monitoring. The FHR was registered using external 
signal unless there was suboptimal signal, or any other indication for use of scalp 
electrode. The EFM signal was registered at a paper speed of 1 cm / minute. 
 
CTG pattern definitions 
In Study III, the CTG interpretation by the blinded reviewer followed current Swedish 
guidelines,
64
 which are based on the FIGO guidelines.
56
 The CTG traces were 
interpreted with focus on the last 60 minutes prior to each FBS, with a structured 
documentation of baseline, (<110bmp=bradycardia, 110-150=normal, >150= 
tachycardia, variability (<2=absent, 2-4=reduced, 5-25=normal, >25=increased), 
accelerations (>15bpm, >15 seconds), decelerations (>15 bpm, > 15 seconds) and 
contractions. Severe variable decelerations were defined as having a variable shape, an 
abrupt fall from baseline FHR to nadir of deceleration, and duration > 60 seconds 
before return to baseline. Late decelerations were defined as start of deceleration after 
peak of contraction, a uniform shape and a gradual fall to nadir of deceleration. Early 
decelerations (uniform shape starting before peak of contraction) and simple variable 
decelerations (abrupt FHR fall and duration < 60 seconds) were referred to the normal 
group. We defined a bradycardic episode as baseline FHR < 110 for > 3 minutes 
occurring within 30 minutes before sampling, including prolonged decelerations (< 10 
minutes) and bradycardia for > 10 minutes. 
 
FETAL BLOOD SAMPLING 
Fetal blood sampling was performed with the woman either in left-lateral recumbent 
position or supine and her legs in stirrups, as the clinician preferred. An amnioscope 
was introduced into the vagina and densely applied to the fetal head. The fetal scalp 
was wiped dry from amniotic fluid and silicone gel was applied. After minimal 
incision, blood was collected in a glass capillary tube; for pH-analysis at least half of 
the capillary tube was filled, for lactate analysis the sufficient amount was 5 µl. Lactate 
analysis was carried out immediately at the bedside with the lactate meter Lactate 
Pro™ (Arkray, Kyoto, Japan). The meters were calibrated every 50th analysis.  
 
The meter uses an enzymatic reaction with lactate oxidase and potassium ferrocyanide 
as an electron mediator. The meter measures the magnitude of the anodic current of the 
reduced mediator by the enzymatic reaction as shown in Figure 8, and displays the 
lactate concentration 60 seconds after a blood sample (5 µl) is applied.  
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Figure 8. Enzymatic reaction in the Lactate Pro™ 
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Cord blood sampling was performed immediately after delivery as a routine at all 
deliveries. Samples were taken by the assistant nurse at vaginal deliveries, and by the 
surgeon or assistant at caesarean deliveries. Umbilical artery and vein were punctured 
separately and approximately 2 ml of blood was drawn into preheparinized plastic 
syringes.  
Blood gas and pH determinations were performed on ABL 800 Flex (Radiometer, 
Copenhagen) in study III and IV. In Study I and II, the ten obstetric units participating 
in the RCT used different blood gas analyzers, and therefore, quality checks of the acid-
base measurements were performed every month during the study, by an independent 
company (Equalis). All departments were sent standard solutions for analysis and 
comparison between analyzers. 
 
STATISTICS 
Statistical analyses were performed with Statistica software, v. 10.0-12.0, StatSoft, 
Tulsa, USA. Values are presented as medians, ranges and percentiles due to non-
normal distribution (Studies I - IV). Comparisons between two continuous variables 
were tested with the Mann-Whitney U-test, and between more than two groups with 
Kruskal-Wallis test (Studies I - IV). Correlation between two variables was estimated 
using Spearman rank correlation (Studies I-II). Comparisons of proportions between 
groups were performed with Chi-square test and Fisher’s exact test where appropriate 
(Studies I – IV). Logistic regression was used to calculate odds ratio (OR) and to 
control for confounders (Study IV). A p-value <0.05 was considered statistically 
significant. 
 
ETHICS 
All studies were approved by the Regional Ethics Committee of the Karolinska 
Institutet in Stockholm, Sweden. 
D-nr: 02-109 (Study I-II) 
D-nr: 2008/1618-31, 2011/478-32 (Study III-IV) 
   31 
RESULTS 
NEONATAL OUTCOME AFTER SEVERE INTRAPARTUM ACIDEMIA – 
STUDY I 
There were 2301 lactate analyses in 1355 women in the lactate arm. Median and 95
th
 
percentile values of the 2301 analyses were 2.9 mmol/L and 6.6 mmol/L, respectively. 
In the pH analysis arm, the corresponding values from 1628 pH analyses in 1008 
women were 7.30 (median) and 7.17 (5
th
 percentile).  
Analyses of the last FBS in all cases of our study population with FBSs upon CTG 
indications similar to the study by Kruger et al,
124
 revealed the 75
th
 percentile of lactate 
concentration at 4.3 mmol/L and corresponding 25
th
 percentile pH value of 7.25. 
 
Eighty-five out of 1355 fetuses in the group with lactate analysis at FBS had lactate 
concentration > 6.6 mmol/L, and 68 out of 1008 fetuses in the group with pH analysis 
at FBS had a pH value < 7.17.  
Severe neonatal morbidity occurred in 10% or less in this high risk population with 
scalp blood values > 95
th
 percentile in the lactate group or < 5
th
 percentile in the pH 
group. Neonatal outcome is shown in Table 6.  
 
Of these 154 infants with severe intrapartum acidemia, defined as above, 12 (7.8%) had 
an UA-pH < 7.00, 16 (10.4%) had an Apgar score < 7 at 5 minutes, and 4 (2.6%) had 
hypoxic ischemic encephalopathy. There were no significant differences in neonatal 
outcomes between the two groups.  
 
 
Table 6. Neonatal outcome in 154 cases with severe intrapartum acidemia. 
 
 
 
Scalp lactate > 6.6 
mmol/l N=85 (%) 
Scalp pH < 7.17 
N=69 (%) 
 
p-value 
UA-pH <7.00 8 (9.4) 4 (5.8) 0.41 
UA-pH <7.10 14 (16.5) 20 (29.0) 0.06 
Metabolic acidemia 1 (1.2) 7 (10.1) 0.02 
Apgar < 7 at 1 min 28 (32.9) 31 (44.9) 0.13 
Apgar <7 at 5 min 9 (10.6) 7 (10.1) 0.93 
Apgar <4 at 5 min 3 (3.5)  3 (4.3) 0.79 
NICU admission 25 (29.4) 18 (26.1) 0.65 
HIE 2 (2.4) 2 (2.9) 0.83 
MAS 1 (1.2) 0 0.37 
UA-pH=umbilical artery pH 
NICU= neonatal intensive care unit 
HIE=hypoxic ischemic encephalopathy 
MAS=meconium aspiration syndrome 
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The proportion of operative vaginal deliveries was higher in the group with pH 
analysis, (Table 7) and the time interval from sampling to delivery was shorter than in 
the lactate group (median 16 vs 21 minutes, p-value 0.01). Delivery within 15 minutes 
after FBS occurred in 22/85 (26.8%) in the lactate analysis group and in 28/69 (40.6%) 
in the pH analysis group (p=0.053). Among the cesarean deliveries, the proportion of 
immediate cesarean delivery was higher in the pH group. 
 
Correlation between scalp blood lactate and UA-pH at delivery was R=-0.21 (p<0.05) 
and the corresponding value for scalp blood pH was R=0.40 (P<0.05). 
 
 
Table 7. Delivery mode in groups with lactate analysis and pH analysis at FBS, 
respectively 
 Scalp lactate group 
N=85 (%) 
Scalp pH group 
N=69 (%) 
p-values 
SVD
 
5 (5.9) 8 (11.6) 0.20 
VE / forceps 21 (24.7) 26 (37.7) 0.08 
Cesarean delivery 59 (69.4) 35 (50.7) 0.02 
Emergency
a 
39 (45.9) 13 (18.8) 
0.006
c 
Immediate
b 
20 (23.5) 22 (31.9) 
SVD=spontaneous vaginal delivery, VE=vacuum extraction 
a
 regional analgesia, time taken for routine preoperative preparations 
b
 general anesthesia, no preoperative preparations 
c
 immediate vs emergency 
 
 
 
 
 
 
HYPOXIA AND LACTATE PRODUCTION IN THE IUGR FETUS – STUDY II 
The proportions of SGA and large for gestational age (LGA) fetuses were 5.3% and 
3.3% respectively. Compared with mothers of AGA and SGA infants, mothers of LGA 
infants were more often multiparous, had a shorter gestational age and had more often a 
caesarean delivery. 
 
The median scalp lactate concentration in the SGA (n=72), AGA (n=1237) and LGA 
(n=45) groups were 3.8, 3.0 and 2.2 mmol/l, respectively. The median lactate 
concentration in the SGA group was significantly higher than in the AGA group 
(p=0,017), and the median lactate concentration in the LGA group was significantly 
lower than that in the AGA group (p=0.009). Distributions are shown in Figure 9. 
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Figure 9. Median lactate concentration in the total study population by birth weight 
group.  
 
SGA=small for gestational age, AGA=appropriate for gestational age, LGA=large for 
gestational age, * SGA versus AGA, ** LGA versus AGA 
 
In the subgroups with scalp blood lactate concentration > 4.8 mmol/L (SGA, n=19; 
AGA, n=247; LGA, n=8), the median (range) values were 6.2 (4.9-14.6) for SGA, 5.9 
(4.9-15.9) for AGA and 5.7 (5.0-7.9) for LGA. In these subgroups with lactemia, there 
were no significant differences between the SGA and AGA groups, the LGA and AGA 
groups or the SGA and LGA groups. (p = 0.65, p = 0.98 and p = 0.81 respectively). The 
distributions are shown in Figure 10. 
 
Figure 10. Median lactate concentration in acidemic fetuses in the birth weight groups. 
 
SGA=small for gestational age, AGA=appropriate for gestational age, LGA=large for 
gestational age, * SGA versus AGA, ** LGA versus AGA  
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The proportions of newborns with UA-pH < 7.00, metabolic acidosis or Apgar score < 
7 at 5 minutes did not differ between the birth weight groups, neither when comparing 
all cases nor in the subanalysis of those with intrapartum acidemia (Table 8). 
 
Table 8. Neonatal outcome in the birth weight groups 
 SGA n (%) AGA
a  
n (%) LGA n (%)  
Total number
b 
72 1237 45 
p-value
c
 
(SGA/LGA) 
UA-pH<7.10 4 (6.2) 106 (9.2) 3 (7.0) 0.40/0.62 
UA-pH<7.0 0 (0.0) 20 (1.7) 0 (0.0) 0.28/0.38 
Metabolic acidemia 1 (1.5) 41 (3.6) 0 (0.0) 0.38/0.21 
Apgar < 7 at 5 min 1 (1.4) 40 (3.2) 1 (2.3) 0.38/0.7 
N with scalp lactate 
> 4.8 mmol/L
d 19 247 8 
p-value
e
 
(SGA/LGA) 
UA-pH<7.10 2 (10.6) 35 (15.2) 2 (25) 0.44/0.36 
UA-pH<7.0 0 (0.0) 10 (4.3) 0 (0.0) 0.45/0.71 
Metabolic acidemia 1 (5.3) 18 (7.8) 0 (0.0) 0.57/0.53 
Apgar < 7 at 5 min 1 (5.3) 21 (9.1) 1 (12 .5) 0.52/0.52 
SGA=small for gestational age, AGA=appropriate for gestational age, LGA=large for 
gestational age, UA-pH=umbilical artery pH 
a
 reference group 
b 
numbers with full acid-base data were 65, 1149 and 43 respectively 
c
 X
2
-test, p-value SGA: SGA vs. AGA; p-value LGA: LGA vs. AGA 
d 
numbers with full acid-base data were 19, 231 and 8 respectively 
e
 Fishers exact test, p-value SGA: SGA vs. AGA; p-value LGA: LGA vs. AGA 
 
The correlation between lactate and weight deviation was analyzed in the SGA group 
separately. There was a weak but significant negative correlation between birth weight 
deviation and lactate concentration (ρ = - 0.24, p < 0.05) (Figure 11). 
 
Figure 11. Correlation between lactate concentration and fetal weight deviation in the 
SGA group. 
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CARDIOTOCOGRAPHY PATTERNS AND RISK OF ACIDEMIA – STUDY III 
During the study period, FBS was performed in approximately 11 % of all labors at the 
labor ward where the study was conducted. There were 2134 FBS performed on 1070 
women, with a median of two samplings and range 1-8. Sixty-eight percent had their 
first FBS during first stage of labor and 92 % had internal CTG monitoring.  
The blinded reviewer interpreted the CTG pattern prior to the first FBS as having a 
normal baseline and variability without serious decelerations in nearly 23 % of cases, 
and these will be referred to as the group with normal CTG trace. There were simple 
variable or early decelerations in 75 % and absence of accelerations in half of these 
cases. The indication for FBS according to the attending physician had been either 
another interpretation of decelerations or variability, or absence of accelerations in 
these cases. 
Reduced variability, tachycardia and the combination of the two, implied FBS in 12-
14%. Sever variable decelerations were twice as common as late decelerations, 12 % 
versus 5 %. Decelerations with tachycardia and/or reduced variability were present in 
approximately 3 % of cases (Table 9). 
At the first FBS, cases with normal baseline and variability without serious 
decelerations had normal lactate concentrations in 97.5%, and isolated reduced 
variability was associated with a similar high proportion of normal lactate 
concentrations (Table 9). Within the group with reduced variability, the absence of 
accelerations for more than 60 minutes did not significantly increase the proportion of 
acidemia at FBS (4.0% [CI 95% 1.3-6.7%]). 
 
Cases with serious (severe variable or late) decelerations had a tendency towards higher 
prevalence of lactacidemia compared with cases with tachycardia (14.2% and 13.8% vs 
8.1% [ns]), even when the tachycardia was accompanied by a reduced variability 
(6.0%).  
The CTG patterns with the highest frequency of pathological lactate concentration (> 
4.8 mmol/L) at FBS were severe variable or late decelerations in combination with 
tachycardia (25% and 20% respectively). 
 
The median lactate concentration was not higher in the group with isolated reduced 
variability than in the group with a normal CTG trace. Cases with tachycardia had only 
a slightly higher median lactate concentration than cases with a normal CTG trace (2.4 
mmol/L vs 2.2 mmol/L), unless the tachycardia was accompanied by serious 
decelerations (Table 10).  
The median lactate concentrations were in these cases 1.6 mmol/L and 0.9 mmol/L 
higher than in the reference group. If cases with maternal fever (>38.0°C) were 
excluded in cases with tachycardia the proportion of lactacidemia did not change. 
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Table 9. Proportions of fetal lactacidemia at first FBS in groups with different CTG 
patterns. 
 
CTG-pattern 
Total 
numbers 
(%) 
Numbers with 
lactate >4.8 
mmol/L 
% (95% CI) 
P-
value
a 
Normal baseline and 
variability 
242 (22.6) 6 2.5 (0.1-4.5)  
Reduced variability 154 (14.4) 4 2.6 (0.1-5.1) 1.0 
Absent variability 32 (3.0) 4 12.5 (0.4-24.6) 0.020 
Increased variability 10 (0.9) 2 20.0 (0.0-50.2) 0.035 
Bradycardic episode 46 (4.3) 10 21.7 (9.4-34.1) <0.001 
Tachycardia 124 (11.6) 10 8.1 (3.2-12.9) 0.027 
Tachycardia + reduced 
variability 
149 (13.9) 9 6.0 (2.2-9.9) 0.102 
Severe variable decelerations 127 (11.9) 18 14.2 (8.0-20.3) <0.001 
Late decelerations 58 (5.4) 8 13.8 (4.6-22.9) 0.001 
Severe variable decelerations 
+ reduced variability 
28 (2.6) 4 14.3 (0.5-28.1) 0.013 
Late decelerations + reduced 
variability 
25 (2.3) 3 12.0 (0.0-25.7) 0.042 
Severe  variable decelerations 
+ tachycardia 
32 (3.0) 8 25.0 (9.1-40.9) <0.001 
Late decelerations + 
tachycardia 
30 (2.8) 6 20.0 (4.8-35.2) 0.001 
Missing + undefinable pattern 13 (1.2) 2 15.4 0.057 
All groups 1070 94 8.8  
a 
p-value calculated with two-tailed Fisher’s exact test in comparison with normal CTG 
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Table 10. Median of lactate concentration at first FBS in groups with different CTG 
patterns. 
CTG-pattern 
median 
(mmol/L) 
25
th
 – 75th 
percentile 
P-
value
a 
Normal baseline and variability (242) 2.2 1.8-3.1  
Reduced variability (154) 2.15 1.7-2.6 0.0176 
Absent variability (32) 2.35 1.9-3.2 0.833 
Increased variability (10) 3.4 2.6-4.1 0.008 
Bradycardic episode (46) 3.15 2.2-4.4 <0.001 
Tachycardia (124) 2.4 2.0-3.4 0.0125 
Tachycardia + reduced variability (149) 2.4 1.9-3.3 0.223 
Severe  variable decelerations (127) 3.2 2.3-4.2 <0.001 
Late decelerations (58) 3.2 2.2-4.1 <0.001 
Severe variable decelerations + reduced 
variability (28) 
3.1 2.2-4.1 <0.001 
Late decelerations + reduced variability 
(25) 
3.2 2.7-4.1 <0.001 
Severe variable decelerations + 
tachycardia (32) 
3.8 3.1-4.8 <0.001 
Late decelerations + tachycardia (30) 3.1 2.4-4.7 <0.001 
Missing + undefinable pattern (13) 3.2 1.4-5.3 0.478 
Total 2.6 2.0-3.4  
a
 p-value calculated with Mann-Withney test compared with normal baseline and 
variability. 
 
 
Since approximately half of the study population underwent more than one FBS during 
labor, the frequency of increased lactate concentration at the last FBS also was 
calculated. Cases with active pushing prior to sampling were excluded in these 
calculations.  
The rate of increased lactate concentration was 4.8 % in the group with normal baseline 
and variability, and 22 % if either late or severe variable decelerations occurred. If 
either of these decelerations occurred together with reduced variability the proportion 
of acidemia was 29 %, and tachycardia accompanied by decelerations was the pattern 
with the highest proportion of acidemia at FBS (Table 11). The median lactate 
concentration was still not increased in the group with isolated reduced variability, but 
nearly doubled in cases with tachycardia combined with serious decelerations 
compared with cases with a normal CTG trace (Table 12). 
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Table 11. Proportions of fetal lactacidemia at last FBS
a
 in groups with different CTG 
patterns. 
 
CTG-pattern 
Total 
numbers
a
 
(%) 
Numbers with 
lactate >4.8 
mmol/L 
% (95% CI) 
P-
value
b 
Normal baseline and 
variability 
187 (21.1) 9 4.8 (1.7-7.9)  
Reduced variability 113 (12.7) 5 4.4 (0.6-8.3) 1.0 
Absent variability 32 (3.6) 7 21.9 (6.7-37.1) 0.003 
Increased variability 7 (0.8) 2 28.6 (0-73.7) 0.053 
Bradycardic episode 36 (4.1) 12 33.3 (17.2-49.5) <0.001 
Tachycardia 106 (11.9) 16 15.1 (8.2-22.0) 0.004 
Tachycardia + reduced 
variability 
128 (14.4) 7 5.5 (1.5-9.5) 0.800 
Severe  variable 
decelerations 
97 (10.9) 21 21.6 (13.3-30.0) <0.001 
Late decelerations 49 (5.5) 11 22.4 (10.3-34.6) <0.001 
Severe variable 
decelerations + reduced 
variability 
28 (3.2) 8 28.6 (10.7-46.4) <0.001 
Late decelerations + 
reduced variability 
34 (3.8) 10 29.4 (13.3-45.5) <0.001 
Severe variable 
decelerations + tachycardia 
33 (3.7) 16 48.5 (30.5-66.5) <0.001 
Late decelerations + 
tachycardia 
30 (3.4) 10 33.3 (15.4-51.2) <0.001 
Missing + undefinable 
pattern 
8 (0.9) 2 25.0 0.067 
All groups 888 136 15.3  
a
 cases with active pushing prior to sampling excluded 
b 
p calculated with two-tailed Fisher’s exact test compared with normal CTG group 
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Table 12. Median of lactate concentration at last FBS
a
 in groups with different CTG 
patterns. 
CTG-pattern (n) 
median 
(mmol/L) 
25
th
 – 75th 
percentile 
P-
value
b 
Normal baseline and variability (187) 2.3 1.9-3.2  
Reduced variability (113) 2.3 1.8-2.9 0.20 
Absent variability (32) 2.6 1.8-4.4 0.373 
Increased variability (7) 3.1 2.1-5.7 0.077 
Bradycardic episode (36) 3.3 2.7-5.2 <0.001 
Tachycardia (106) 3.0 2.2-4.0 <0.001 
Tachycardia + reduced variability (128) 2.5 2.0-3.3 0.204 
Severe  variable decelerations (96) 3.4 2.4-4.4 <0.001 
Late decelerations (49) 3.2 2.4-4.6 <0.001 
Severe variable decelerations + reduced 
variability (28) 
3.8 2.5-5.0 <0.001 
Late decelerations + reduced variability 
(34) 
4.5 3.2-5.0 <0.001 
Severe variable decelerations + 
tachycardia (33) 
4.4 3.3-5.4 <0.001 
Late decelerations + tachycardia (30) 4.2 3.1-5.1 <0.001 
Missing + undefinable pattern (11) 4.1 3.8-6.1 0.013 
Total (888) 2.8 2.1-4.0  
a
 cases with active pushing prior to sampling excluded 
b
 p-value calculated with Mann-Withney test compared with normal baseline and 
variability 
 
 
 
At the first FBS, there were 148 fetuses with an acceleration as a response of FBS, and 
two of these had lactacidemia at sampling. The proportion of acidemia among fetuses 
without a distinct acceleration at FBS was 76/668. At the last FBS the differences in 
prevalence of acidemia between cases with acceleration and those without were even 
more pronounced (Table 13). 
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Table 13. Proportions of fetal lactacidemia at first and last FBS
a
 in groups with and 
without adequate acceleration at FBS 
 First FBS n (%) 
P-
value
b Last FBS
a
 n (%) P-value
b 
Acceleration at FBS 2/148 (1.3)  2/108 (1.8)  
Acceleration with only 
10 bpm at FBS 
8/143 (5.6) 0.05 6/110 (5.5) 0.16 
Indefinable pattern at 
FBS 
8/111 (7.2) 0.02 18/95 (21.1) <0.001 
No acceleration at 
FBS 
76/668 (11.4) 0.00 107/575 (18.6) <0.001 
Total 94/1070 (8.8)  133/888 (15.0)  
FBS= fetal scalp blood sampling 
a
 active pushing prior to sampling excluded 
b
 p-value calculated with Chi square test 
 
 
 
NEONATAL OUTCOME AND DELIVERY MODE AFTER REPEATED FBS – 
STUDY IV 
During the study period there were 2134 FBS performed on 1070 women in labor, 
which constituted approximately 11 % of all deliveries at the labor ward during the 
study period. The proportion of nulliparous women was higher and labor was more 
often induced in this cohort of women with FBS compared with the total delivering 
population. There were 297 women having at least one maternal complication (e.g. 
diabetes, preeclampsia, hypertension), and 165 had at least one fetal complication (e.g. 
known IUGR, oligohydramnios, immunization). 
The median number of FBS was two, 48% of the population had only one FBS and the 
range was 1-8. Approximately two thirds of the population, 795 women, had maximum 
two samplings taken during their course of labor, and 275 women underwent three or 
more FBS.  
Median time from first FBS to delivery was 88 minutes for those with 1-2 samplings 
and 240 minutes for those with 3 or more samplings (p=0.00). There were no 
differences in proportions of nulliparous women or women with a history of previous 
cesarean delivery between the groups. Maternal age did not differ, but there was a 
higher proportion of women with induced labor in the group with three or more FBS, 
and their gestational age at delivery was on average three days longer compared with 
women with 1-2 samplings. 
At the last FBS, the median lactate concentration was higher in the group with multiple 
samplings. The proportion of cases with increased lactate concentration (>4.8 mmol/l) 
at the last FBS was also higher, and indication for instrumental or operative delivery 
was more often fetal distress in this group, compared with the group with one or two 
samplings. Numbers are shown in Table 14. 
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Table 14. Lactate concentrations at the last FBS and rates of operative delivery due to 
fetal distress. 
 
Cases with 1-2 
FBS during labour 
Cases with ≥ 3 
FBS during labour 
P-value 
Lactate concentration 
median (range) 
2.7 mmol/L 
(1.0-11.2) 
3.9 mmol/L 
(1.2-9.1) 
<0.001
a 
Cases with lactate >4.8 mmol/L 
n (%) 
99/795 (12.4) 76/275 (27.6) <0.001
b 
Cases with fetal distress as 
indication for delivery n (%) 
among cases with operative 
delivery
c 
228/426 (53.5) 162/221 (73.3) <0.001
b 
a 
p-value calculated with Mann-Whitney U test 
 
b 
p-value calculated with Chi-square test 
c 
instrumental vaginal and caesarean delivery 
 
As shown in Table 15, neonatal outcome did not differ between the groups concerning 
short-term neonatal outcome. There were similar proportions of neonates with 
metabolic acidemia or low Apgar score at 5 minutes in the groups with 1-2 and 3 or 
more FBS. There were neither a difference in proportions of babies needing respiratory 
support or admission to the neonatal intensive care unit (NICU). 
Among women who underwent one or two FBS, 46 % had a spontaneous vaginal 
delivery (SVD) in contrast to 19 % of those having three or more FBS during labor. Of 
those delivered operatively, 38 % had three or more FBS, compared with 12 % of those 
delivered normally (Table 15). 
 
Table 15. Neonatal outcome and delivery mode in groups with 1-2 FBS and ≥ 3 FBS. 
N(%).  
 1-2 FBS ≥ 3 FBS P-valuea 
Apgar score < 7 at 5 minutes
b 
9/794 (1.1) 6/272 (2.2) 0.19 
UA-pH < 7.0
c 
7/618 (1.1) 2/234 (0.9) 0.72 
UA-pH < 7.10
c 
34/618 (5.5) 7/234 (3.0) 0.12 
Metabolic acidemia
cd 
11/616 (1.8) 3/234 (1.3) 0.61 
HIE 0/795 (0.0) 1/275 (0.4) 0.09 
NICU admission 42/795 (4.3) 17/275 (6.2) 0.57 
Spontaneous vaginal delivery 366 (46.0) 52 (18.9) 0.000 
Instrumental vaginal delivery 244 (30.7) 108 (39.3) 0.009 
Caesarean delivery 185 (23.3) 115 (41.8) 0.000 
UA = umbilical artery, HIE=hypoxic ischemic encephalopathy, NICU=neonatal 
intensive care unit 
a 
p-value calculated with Chi-square test 
b 
4 cases with no Apgar score noted  
c 
218 cases with no or incomplete umbilical blood samples noted 
d 
metabolic acidemia defined as pH < 7.05 and base deficitblood >12. 
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Adjustment for probable confounders revealed that women with a previous cesarean 
delivery, those with induced labor and nulliparous women had an increased risk of 
abdominal delivery as expected, but the exposure to three or more FBS was still a 
significant risk factor for abdominal delivery (Table 16). 
 
FBS in early labor (cervical status 2-4 cm) was a risk factor with adjusted OR for 
cesarean delivery of 4.4 % (95 % CI 2.9-6.7). Adjustment for time from first FBS and 
cervical status at first FBS did not reduce the OR of multiple FBS. 
  
 
Table 16. Crude and adjusted OR for caesarean delivery 
 
 
 
N 
 
Caesarean 
delivery 
rate (%) 
Crude 
OR 
95% CI 
Adj 
OR
a 95% CI 
Maternal age ≤24 137 23.4 0.79 0.52-1.22 0.82 0.53-1.72 
 25 – 35 725 27.7 Ref  Ref  
 ≥36 208 32.2 1.24 0.89-1.73 1.20 0.87-1.72 
Parity and 
previous 
caesarean 
Multiparous 
without 
previous 
cesarean 
189 20.1 Ref  Ref  
 Nulliparous 772 29.0 1.62 1.10-2.39 1.61 1.07-2.42 
 Multiparous 
with previous 
cesarean 
109 34.9 2.13 1.25-3.62 1.97 1.14-3.41 
Gestational 
age 
<37w 36 27.8 1.13 0.53-2.39 1.12 0.52-2.41 
 37-41 w 724 25.4 Ref  Ref  
 >41 w 310 34.2 1.52 1.14-2.03 1.30 0.96-1.76 
Start of labour Spontaneous 690 23.8 Ref    
 Induction 380 35.8 1.79 1.36-2.35 1.60 1.19-2.13 
Oxytocin 
augmentation 
No 301 21.3 Ref    
 Yes 769 30.7 1.64 1.20-2.25 1.27 0.91-1.77 
FBSs during 
labour 
≤2 FBS 795 23.3 Ref  Ref  
 ≥3 FBS 275 41.8 2.37 1.77-3.17 2.05 1.52-2.78 
a
 adjusted for all other parameters in the model 
 
FBS in early labor (cervical status 2-4 cm) was a risk factor with adjusted OR for 
cesarean delivery of 4.4 (95 % CI 2.9-6.7). Adjustment for time from first FBS and 
cervical status at first FBS did not reduce the OR of multiple FBS. 
 
As shown above in Table 14, of the 275 women with 3 or more FBS, 199 had normal 
results at the last FBS. Ninety-nine of them were in first stage of labor at the time of 
sampling, and 43 of these 99 women, were vaginally delivered. 
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DISCUSSION 
The discussion will comment the studies in the order III, II, IV and I, with the purpose 
to follow the course of parturition. 
 
MAIN FINDINGS 
Fetuses that during labour had a CTG trace with isolated reduced variability did not 
have a higher median lactate concentration in scalp blood than fetuses with a normal 
CTG trace, not even in the absence of accelerations. Also the proportion of 
lactacidemia at FBS was equal to the group with a normal CTG tracing. The two types 
of serious decelerations i.e. severe variable and late, correlated equally to increased 
proportions of lactacidemia at FBS, and the median fetal scalp blood lactate at the first 
FBS was 1 mmol/L higher than in fetuses with normal CTG tracings. Fetuses with 
tachycardia in combination with either of the two types of serious decelerations had the 
highest proportion of lactacidemia at FBS, and at the last sampling, a doubling of the 
median lactate concentration compared with fetuses having normal tracings. 
  
Fetuses that were SGA had on average slightly higher lactate concentrations than AGA 
fetuses. The proportion of fetuses with concentrations above the cutoff value set for 
acidemia was equal between SGA and AGA fetuses. Among fetuses with lactate 
concentrations above the cutoff for acidemia at FBS, the median lactate concentration 
did not differ between the SGA and the AGA fetuses, thus showing that SGA fetuses 
could produce lactate to the same extent as AGA fetuses in response to hypoxia in spite 
of smaller glycogen reserves. 
 
Neonatal outcome was not negatively affected in cases where prolonged duration of 
CTG abnormalities had caused ≥ 3 FBSs compared with labors where only 1-2 FBSs 
had been performed. The rates of Apgar score < 7 at 5 minutes, metabolic acidemia and 
admission to NICU was equally low in the group with repeated FBSs as in the group 
with occasional FBS in spite of a longer duration of a non-reassuring CTG. However, 
the cesarean delivery rate was increased from 23% to 42 % in labors where CTG 
changes had led to more than 2 FBSs, and the OR was only marginally affected by 
known risk factors for cesarean delivery. 
 
The risk of serious neonatal complications was low even in cases with severe 
intrapartum acidemia, i.e. lactate > 95
th
 percentile or pH < the 5
th
 percentile of the study 
population, where all underwent FBS due to a non-reassuring CTG trace. Among these 
high-risk cases, i.e. the 5 % of fetuses with the most pronounced acidemia at FBS, the 
proportion of umbilical artery pH < 7.00 was less than 10 %, and the proportion of HIE 
was less than 3 %. There were no differences between the groups with lactate and pH 
analysis. The time interval from FBS to delivery was shorter in the group with pH 
analysis, partly explainable by a higher proportion of vaginal deliveries, and partly by a 
higher proportion of immediate deliveries among the cesarean sections.  
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INTERPRETATION 
Besides auscultation, CTG can be regarded as the main method for intrapartum fetal 
surveillance. CTG is considered a valuable screening method due to its high sensitivity, 
with a low risk of false negative cases. The specificity is however low, with many 
healthy fetuses having non-reassuring CTG patterns at some periods during labour, and 
this leads to a substantial increase in cesarean deliveries, compared with intermittent 
auscultation.
1
  
The primary goal of intrapartum fetal surveillance is to identify those fetuses who do 
not cope with the stress of a vaginal delivery, i.e. the uterine contractions with 
concomitant decrease in oxygen supply, and to enable intervention before organ 
damage has occurred. At the same time, we do not want to expose laboring women to 
unnecessary interventions with short-, and long-term risks attached.  
FBS with lactate analysis is a simple and reliable way to rule out metabolic acidemia in 
cases with a false positive non-reassuring CTG since false negative tests with FBS are 
unlikely.
126
 
Fetal surveillance with CTG and FBS can however not guard against damage in fetuses 
that before start of labor have already been exposed to chronic hypoxia or an ischemic 
event. In a large retrospective study, approximately 50 % of cases with HIE were of 
antenatal origin.
130
 There might be no ongoing acidemia, and the injury can still already 
have been established, but intervention can prevent further worsening. However, if a 
healthy fetus enters labor and there is a gradual development of hypoxia, FBS can 
provide preventive measures, and with timely intervention delivery of a healthy no-
acidemic baby can be expected. 
 
FBS with lactate analysis also offers a feasible way to rule in cases with a true positive 
non-reassuring CTG due to anaerobic metabolism and thereby metabolic acidemia with 
increased lactate concentration. Several studies have shown that lactate measured in 
fetal blood as well under normoxic as under hypoxic circumstances is of fetal and not 
maternal origin.
23, 24, 127
 It is also shown that increased fetal glucose levels that are due 
to administration of 5% glucose or beta-mimetic drugs to the mother does not increase 
fetal lactate concentration.
131, 132
 Accordingly, since the main reason for increased 
lactate production is hypoxia with anaerobic metabolism false positive tests are 
unlikely in a correctly collected blood sample. 
 
It is important to understand that the read-off concentration is affected by analysis type; 
i.e. whole blood with intact erythrocytes, whole hemolysed blood, or plasma, as well as 
the type of analyzing machine, with the consequence that cutoff level for normal lactate 
concentration cannot always be fully translated between different studies and 
guidelines.
133
 
 
Cardiotocographic findings as causes or signs of fetal acidemia 
Common causes of concern during labor are absence of FHR accelerations, isolated 
reduced variability and simple variable decelerations with large amplitude, all of 
uncertain value regarding the risk of developing fetal acidemia.  
There are animal studies elucidating pathophysiologic origins to certain CTG patterns, 
but many fetuses with CTG patterns that have a hypoxic explanation are born non-
acidemic in a vigorous state. Human studies have correlated certain CTG patterns with 
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neonatal outcome, e.g. acidemia in umbilical artery,
77, 88
 and cerebral palsy,
76
 but 
umbilical acid-base status is influenced by the action taken and time interval to delivery 
and intrapartum asphyxia is only a minor contribution to cerebral palsy.  
The most objective way to identify the CTG abnormalities that either affects the fetus 
to engage anaerobic metabolism, or are signs of an ongoing anaerobic metabolism, 
would be to measure the level of eventual metabolic acidemia at the time point of 
ongoing CTG pattern. Clinical studies of the relationship between different CTG 
patterns and acid base status in fetal scalp blood have been small with study 
populations between 85 and 279 women.
71, 87, 134
 They were performed when the CTG 
technology was relatively new, and definitions of CTG parameters were different from 
guidelines used today. They all measured pH in fetal scalp blood, thus not being able to 
differentiate between respiratory acidemia which is harmless to the fetus,
21
 and the 
potentially dangerous metabolic acidemia, which always is caused by insufficient 
oxygen supply and anaerobic metabolism. 
The hitherto largest study is to our knowledge the study by Beard et al., that in 1969 
evaluated CTG patterns and scalp blood pH in an observational cohort study of 279 
high-risk patients during labor. 
Our finding of a low risk of fetal acidemia in cases with tachycardia without 
decelerations as well as a high risk if the tachycardia was accompanied by severe 
variable or late decelerations correlates to their findings. They used the term beat-to-
beat variation, but defined it as a variation in FHR of 5 or less bpm, thus corresponding 
to the currently used terms reduced and absent variability together. Our results are 
therefore not completely comparable; however, in their group with uncomplicated loss 
of beat-to-beat-variation (normal baseline and no decelerations) they reported only a 
slightly lower mean scalp blood pH compared with normal traces, and the mean Apgar 
score was not lower than in the normal group. This can partly be interpreted as in 
accord with our findings.  
They did not specify the duration of the variable decelerations whereas we referred all 
variable decelerations with duration of less than 60 seconds to the normal group. With 
this inclusion regardless of depth of the decelerations we had a negative predictive 
value of 95% for lactacidemia at FBS in the normal group.  
 
We found no association between isolated reduced variability and fetal metabolic 
acidemia in our study. Williams et al. stated in their study that minimal variability (i.e. 
reduced or absent) was the most predictive parameter for acidemia in umbilical artery.
77
 
In the case-control study of 78 cases with cerebral palsy, Nelson et al. reported that 
reduced beat-to-beat variability was associated with a tripling of the risk for cerebral 
palsy.
76
 The CTG traces were not available to the authors, but recorded from birth 
records by the attending physicians, and thereby the group probably consists of both 
reduced and absent variability. Thus there was no information on whether the CTG 
trace hade presented abnormal variability already before start of labor, and since 
cerebral palsy in the majority of cases have antenatal origin, these children might have 
already suffered damage prior to labor and not due to intrapartum hypoxia. 
 
Considering the available scientific knowledge from both animal and human 
observations, it seems reasonable to separate reduced and absent variability in the 
assessment of fetal status. Prolonged duration of reduced variability is one of the more 
common deviations from what is considered a normal CTG pattern during labour (14 % 
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in our study population). Although reduced variability can be of significance as a 
possible sign of hypoxia in the light of mentioned studies, due to the extremely high 
false positive rate and our negative findings, it seems reliable to suggest that one FBS is 
enough to rule out ongoing hypoxia, and that labour can continue without repetitive 
FBSs if the result is normal. 
 
Regarding accelerations, they can be considered as a reliable reassuring sign, but with a 
low specificity just as the entire CTG trace. Accelerations are trustworthy signs of fetal 
well-being, but absence of accelerations is not so informative or predictive. Several 
earlier studies have shown the reliability of stimulation tests in the meaning that a 
provoked acceleration confirms a non-acidemic fetal status.
79
 However, the meta-
analysis of stimulation tests does not comment the large proportion of fetuses without 
response to stimulation. In our study population approximately two thirds had no 
acceleration at FBS, thus, in the majority of cases with a non-reassuring CTG, a 
stimulation test by vaginal palpation would have been of little help in discriminating 
acidemic and non-acidemic fetuses. 
In addition, 60 % of all non-acidemic cases at FBS had no CTG reaction on the 
stimulation by FBS, and merely 15 % of the non-acidemic fetuses reacted with an 
acceleration that filled the criteria (≥15 bpm, ≥15 seconds). This supports the 
usefulness of FBS, since in the majority of cases a stimulation test is of no help in 
exclusion of developing hypoxia. 
 
 
Intrapartum surveillance of the IUGR fetus 
IUGR is often due to a suboptimal function of the placenta, and therefore IUGR fetuses 
can be regarded as being closer to the threshold where the intermittent reduction of 
oxygen supply during labour contractions exceeds the capacity of the fetus. Unless 
serial measurements have been undertaken, IUGR cannot be diagnosed, and thus, SGA 
is often used as a proxy. Our finding of a higher median lactate concentration in the 
SGA group compared with the AGA group is consistent with earlier reports of fetal 
lactate concentrations both antepartum and at delivery,
26, 135
 and are explained as 
caused by mild chronic tissue hypoxia and polycythemia. The lactate concentrations in 
both quoted studies were within normal range, and cannot be transcribed to an acute 
intrapartum hypoxic situation, where lactate can reach four to five times higher 
concentrations than in the antenatal period.
136
 
When looking into the subgroups with intrapartum acidemia i.e. scalp blood lactate > 
4.8 mmol/L, we found no difference in lactate concentrations between birth weight 
groups, and the SGA fetuses reached as high lactate concentrations as the AGA and 
LGA fetuses. We were concerned whether it was only the mildly growth-restricted 
fetuses that could respond to hypoxia with a marked increase in lactate concentration, 
but analysis of the SGA group revealed a weak but significant correlation in the other 
direction, i.e. higher lactate concentrations with larger weight deviation. The SGA 
fetuses were not more often depressed or acidemic at birth than AGA or LGA fetuses. 
We therefore found it reliable to conclude that FBS with lactate analysis is a well-
functioning surveillance method also in labors where intrauterine growth restriction is 
suspected.  
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Labors requiring repeated FBS 
The use of FBS as an adjunct to intrapartum CTG monitoring varies largely between 
countries, with reported frequencies between 3-15 % in some countries,
3, 4, 125, 137
 and 
essentially none in other. The attitude towards the use of FBS can be considered liberal 
at the labor ward where this study was conducted, with a frequency of 11 % of all 
labors, but is comparable to other countries where FBS is a part of intrapartum fetal 
surveillance routines.
4
  
Performance of multiple FBSs during the course of labor can be interpreted as 
prolonged duration of a CTG tracing that is of concern to the attending physician but 
not indicative of immediate delivery. There are no evidence-based guidelines how to 
continue labor when prolonged CTG abnormalities have already caused one or two 
FBSs with normal results, and the CTG continues to be non-reassuring. The National 
Institute of Health and Clinical Excellence (NICE) has published the recommendation 
that a resident should obtain an obstetric opinion from a consultant if a third FBS is 
considered necessary, but this recommendation is bases on consensus rather than 
scientific evidence.
57
 
We showed that, in spite of a larger proportion of lactacidemia in fetal scalp blood at 
the last FBS, there were no more cases of depressed newborns or acidemia in umbilical 
cord in the group with multiple FBSs (≥ 3). This supports earlier findings that increased 
lactate in capillary blood is an early marker in the hypoxic process enabling timely 
intervention before tissue damage has occurred.
115
 A retrospective study of 381 women 
with FBS found a higher proportion of admission to NICU among infants who had 
undergone more than one FBS during labour.
138
 In our considerably larger and 
prospectively collected material, we could not repeat this finding. There were no 
differences in any of the neonatal outcome measures in our study.  
 
Allowing labor to continue the vaginal route in the presence of a non-reassuring CTG is 
safe for the baby when repeated FBS is used as an adjunct to CTG. If the duration of 
CTG abnormalities eventually passes the threshold of fetal reserves, increase in fetal 
lactate concentration will give an early sign of developing hypoxia with possibility for 
the clinician to expedite delivery before the baby’s health is jeopardized. 
 
The consequences of repeated FBS for the woman need to be addressed. In our study 
population, the proportion of cesarean deliveries was doubled (from 23% to 42%) if 
FBS exceeded two samplings, compared with women having 1-2 samplings.  
The finding of a doubled risk of cesarean delivery is in accord with the retrospective 
study by Heazell et al.
138
 They reported an OR of 1.71 for cesarean delivery in women 
who required more than one FBS during labor.  
The procedure of FBS can be uncomfortable for the women, and is sometimes 
described as difficult and time-consuming.
106, 139
 This describing refers however mainly 
to FBS with pH analysis, where there is a considerable difference in failure rate in 
comparison with lactate analysis. The failure rate in pH analysis reflects as well the 
difficulty in collecting 30-50 µL, as the longer time it takes to success in collecting the 
demanded amount of blood. Women’s experience of FBS is not so much studied, but 
Liljeström et al. recently reported that FBS was well tolerated in women who had 
epidural analgesia.
140
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It is not possible to draw conclusions about what impact the use of FBS might have on 
the cesarean delivery rate due to the study design. In the group with ≥ 3 FBS, the last 
sampling was normal in 72.3 % of cases, and half of those (99 cases) were in first stage 
of labor when the last FBS was performed. One can only speculate if continued labour 
would have been an alternative without the possibility to exclude fetal acidemia by 
FBS. Forty-three of these 99 women were vaginally delivered, and there is a 
considerable possibility that all 99 would have been abdominally delivered if FBS had 
not been an option. 
 
 
Neonatal course after exposure to severe intrapartum acidemia 
In labors where the FBS analysis result reveals pronounced lactacidemia, there has 
been uncertainty regarding the level of urgency needed, and a common question asked 
is whether there is linearity in the correlation between fetal scalp blood concentration 
and proportion of neonatal complications, and if it is possible to set a limit where 
immediate delivery is demanded in spite of higher risks of per-, and postoperative 
complications for the mother. 
The study by Kruger et al. set the current used cut-off values (4.8 mmol/L for the 
Lactate Pro™) at the 75th percentile in a study population with FBSs indicated by CTG 
abnormalities.
124
 The lactate value with highest accuracy according to the area under 
the ROC curve for moderate to severe HIE was 6.5 mmol/L, with a sensitivity and 
specificity of 66.7, and 93.7 respectively. Corresponding values for Apgar score < 4 at 
5 minutes was 6.0 mmol/L, 50.0 and 90.4 respectively, and for umbilical artery pH < 
7.00 the values were 5.1 mmol/L, 58.3 and 82.3 respectively. In our study population 
with FBSs upon CTG indications just like Kruger’s study, the 75th percentile was 
lactate concentration 4.3 mmol/L and corresponding 25
th
 percentile pH value 7.25. 
Thus, similar to clinical use of many other diagnostic tests, over time they tend to be 
used in a more “healthy” population, and on milder symptoms, which will affect the 
predictive values, and therefore such calculations would have been of little use, since 
the main goal is to avoid the outcome measure by interventions taken due to the result 
of the diagnostic test. 
The statements possible to make from our study, is that also fetuses diagnosed with 
severe intrapartum acidemia by FBS, i.e. lactate concentration > 6.6 mmol/L or pH < 
7.17, are still at a window of opportunity, with a relatively low risk of being severely 
acidemic or depressed at birth, when prompt action is taken. Most commonly, women 
start labor with the fetus in good condition, and a normal CTG trace at admission. 
When there is gradual development of acidemia, in most cases acute tocolysis with IV 
terbutaline enables time for preoperative preparations and the caesarean delivery to be 
carried out in spinal analgesia within 20-30 minutes after decision. Further statements 
are difficult to make, since courses of labours are influenced by so many factors. The 
absolute scalp blood value can only partly guide us in decision upon how rapid delivery 
should be expedited. Most likely the patient history, e.g. known growth restriction, 
presence of thick meconium, and the CTG pattern preceding the FBS result should 
influence this decision. 
The correlations between last FBS values and UA-pH at delivery were significant, 
however better for FBS pH than FBS lactate. The probable explanation is firstly that in 
the pH group, the same entity is measured in both compartments, i.e. scalp blood and 
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umbilical blood, and secondly, that lactate measurements do not include the respiratory 
contribution to the acidemia. In addition the time from sampling to delivery was longer 
in the lactate group. There was a higher proportion of caesarean deliveries in the lactate 
arm, and it is likely that terbutaline was administered to reduce contractions and further 
stress in many of those cases. Since tocolysis enables reversal of the anaerobic 
metabolism and metabolic acidemia, this also might have contributed to the lower 
correlation in the lactate analysis group. 
 
 
STRENGTHS AND LIMITATIONS 
Data are prospectively collected in large populations in both cohorts of this thesis. The 
first cohort (Study I and II) consists of women in the hitherto largest randomized trial 
comparing pH and lactate in FBS. The second cohort (Study III and IV) consists of all 
consecutive cases with FBS at an obstetric unit with approximately 4500 annual 
deliveries during the study period. The CTG interpretation was blinded as the CTG 
reviewer was not aware of the FBS analysis result at the time of interpretation. The risk 
of failed attempts to perform FBS is small since lactate analysis was used. The reported 
frequency of sampling or analysis failure is 1.2-1.7 % compared with 10-20 % for FBS 
with pH analysis.
105, 106, 126
 The risk of missing data due to unreported cases with FBS is 
small since the FBS results were routinely noted in the medical record. 
 
Studies I and II are secondary analyses of a former RCT, with the objective to compare 
lactate and pH analyses in FBS in the prevention of birth acidemia. Thus, the study was 
not designed to address our hypotheses and issues. 
 
All studies concerning CTG patterns are limited by short-comings in inter-observer 
agreement.
141-143
 We believe our efforts in structuring the CTG interpretation have 
minimized this weakness. Our finding that the two types of serious decelerations 
correlate equally to fetal metabolic acidemia might reduce future inter-observer 
variation regarding decisions due to CTG changes.  
We did not take the duration of different CTG patterns into account; however we 
believe it is unlikely that further subdivision would influence our results, but only make 
it more difficult to apply to clinical practice.  
There is a possibility of selection bias in the proportion of groups in the study 
population as some CTG patterns e.g. persistent bradycardia or absent variability with 
or without decelerations more likely indicate immediate delivery without preceded 
FBS. In these groups the true proportion with lactacidemia are probably higher than in 
our study. Regarding the pattern of isolated reduced variability, we believe our findings 
can be regarded as reliable as it is unlikely that this tracing would cause a decision upon 
immediate delivery.  
 
Birth weight group was used as a proxy for intrauterine growth restriction. SGA and 
IUGR are not entirely synonymous entities, since SGA is a statistical definition based 
on birth weight, gestational age and sex, and IUGR is a functional definition of a fetus 
that, due to placental, maternal or fetal reasons is unable to achieve its predestined 
weight. Thus, a SGA newborn has not necessarily been exposed to IUGR, but can be 
genetically small. More rarely, an AGA newborn can be growth restricted, for example 
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a fetus that genetically would have become LGA, might due to preeclampsia in the 
mother with associated growth restriction only reach AGA. We classified fetuses as 
SGA, AGA or LGA, according to the sex-specific ultrasonically estimated fetal weight 
curves, routinely used in Sweden. The Swedish definition of SGA is a birth weight > 2 
SDs below the mean of estimated fetal growth, i.e. the lowest 2.5
th
 percentile, and 
therefore, our findings should be valid using a more common definition of SGA as less 
than the 10
th
 percentile. 
 
Regarding conclusions on repetitive FBSs, the number of samplings is somehow a 
proxy for duration of CTG changes that are of concern to the attending physician, but 
not alarming enough to cause decision upon immediate delivery. The number of FBSs 
could be inversely related to the physician’s experience of CTG interpretation, in the 
meaning that more junior doctors would take more samples. There is however always 
at least one consultant of the two doctors on call at the labor ward where the study was 
performed, and we find it unlikely that the experience of the attending doctor would 
differ between the groups.  
Another limitation regarding Study IV is that sample size of the study population was 
calculated for other outcomes than acid base status in umbilical artery and admission to 
NICU. However, in comparison with a former retrospective cohort of 381 women 
addressing these issues,
138
 we found it interesting to report that we could not repeat 
their finding of increased NICU admission in our considerably larger material. 
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CONCLUSIONS 
Severe variable decelerations and late decelerations, although of different 
pathophysiological origins, correlate equally to fetal metabolic acidemia and 
distinguishing between them is not crucial in CTG interpretation. A CTG pattern with 
tachycardia in combination with either late or severe variable decelerations was the 
CTG pattern with the highest median lactate concentration and highest rate of 
lactacidemia at FBS. Isolated reduced variability is in most cases not associated with 
lactacidemia in fetal blood, and if developing fetal acidemia is ruled out with one FBS, 
this pattern does not require monitoring with repeat FBSs throughout labour. 
 
The growth restricted fetus can respond to hypoxia adequately and to the same extent as 
appropriately grown fetuses in terms of lactate production, and FBS with lactate 
analysis is a safe surveillance method also in labors with a suspected intrauterine 
growth restriction of the fetus. 
 
If CTG changes require monitoring with repetitive FBSs (≥3), labor is still safe for the 
baby, but the risk of a cesarean delivery is doubled as compared to labors where CTG 
changes has caused 1-2 FBS. Still there is a substantial chance of vaginal delivery. 
 
The risk of neonatal complications is low even in cases with pronounced lactacidemia 
in scalp blood, when proper action is taken. 
Increase in fetal scalp lactate concentration is an early marker of fetal hypoxia and FBS 
with lactate analysis can be used to prevent birth acidemia. FBS with lactate analysis is 
a safe and valuable adjunct to CTG in intrapartum fetal surveillance, with no false 
negative tests. 
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FUTURE PERSPECTIVES 
 
To cite the words of Dr Hon 50 years ago – the sizable task of categorizing CTG in a 
meaningful way is still ongoing. 
 
There are several areas regarding CTG interpretation and FBS that can be further 
investigated. 
 
The aspect of duration of different CTG abnormalities in relation to fetal lactate 
concentration can be further analyzed, with the aim to provide evidence-based and 
possibly more specific guidelines for FBS.  
 
The time interval from most recent acceleration prior to FBS can be explored, to see if 
there is an impact on prevalence of lactacidemia. 
  
In cases with repeated FBS, the dynamics of lactate concentration and increase can 
possibly be elucidated regarding different CTG patterns.  
 
Although there are many existing studies on inter-observer variation in CTG 
interpretation, it would be of interest to evaluate the implication and effects of an 
expanded CTG education program that has been introduced at the department where 
Studies III and IV were performed. One aspect would be to evaluate if an education-
intense approach can reduce inter observer variation, and test the reproducibility of our 
findings. The other aspect would be to examine if education in CTG interpretation and 
fetal pathophysiology has an impact of FBS frequency. 
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POPULÄRVETENSKAPLIG SAMMANFATTNING PÅ 
SVENSKA 
Kardiotokografi (CTG) är förutom periodvis avlyssning av fosterhjärtfrekvensen den 
grundläggande metoden för fosterövervakning under förlossning. Ett normalt CTG-
mönster är ett betryggande tecken på ett väl syresatt foster. Dock gäller inte det 
motsatta, då många friska foster ofta uppvisar CTG-förändringar någon period under 
förlossningen. CTG har således en hög sensitivitet, men låg specificitet med många 
falskt positiva test. CTG kräver dessutom en visuell tolkning vilket medför en avsevärd 
variation mellan olika CTG-bedömare.  
Parallellt med CTG-teknikens införande utvecklades metoden att via blodprovstagning 
från fostrets hårbotten undersöka fosterblodets surhetsgrad via pH-mätning. pH-värdet 
sjunker både vid förhöjd koldioxid-halt utan syrebrist, vilket är vanligt under 
förlossning men inte utgör någon risk för fostret, och vid ökad produktion av mjölksyra 
(laktat) när syretillgången är otillräcklig, och cellerna växlar till icke syrekrävande 
energiproduktion. För att bättre komma åt den för fostret potentiellt hotande typen av 
pH-sänkning undersöktes möjligheten att analysera laktatkoncentrationen i fosterblod.  
 
Metoden är kontrollerad i randomiserade studier och jämförbar med pH analys vad 
gäller barnutfall och kejsarsnittsfrekvens, men har den stora fördelen av enklare 
provtagning och kortare tid till provsvar då metoden endast kräver 5 µl blod, och små 
portabla mätare finns. pH-mätning av fosterblod kräver förhållandevis mycket blod 
(30-50 µl) vilket medför en hög misslyckandegrad i provtagning och/eller blodanalys. 
Mätning av laktathalten i fosterblod är väl utprövad och säker, och används på de flesta 
förlossningskliniker i Sverige och internationellt sett i flera länder. Eftersom riktlinjer 
för CTG-tolkning dock till stor del är expert-utlåtanden och konsensus-dokument, kan 
inte heller riktlinjer för skalpblodprovtagning anses vara evidens-baserade. 
 
Detta avhandlingsarbete har syftat till att ytterligare öka kunskapen om 
laktatkoncentrationen i fosterblod och dess betydelse vid hotande syrebrist hos fostret 
under förlossningen. Ett delsyfte har varit att skapa evidensbaserade grunder för 
kliniska riktlinjer avseende skalpblodprovstagning som fosterövervakning under 
förlossning. 
 
Neonatalt utfall efter uttalad surhetsgrad i skalpblodprov under förlossning – Studie I 
Delarbete I är en subanalys av en randomiserad studie som jämförde mätning av laktat 
och pH-mätning i skalpblodprov under förlossning. Målsättningen för studien var att 
undersöka risken för komplikationer och sjuklighet i nyföddhetstiden hos de fall som 
vid skalpblodprovstagning haft laktatnivåer långt över gränsnivån för att aktivt förlösa 
barnet. Syftet var att kunna ge mer detaljerade riktlinjer för handläggande vid olika 
grader av förhöjd laktatkoncentration. Vid CTG-förändringar som indikerade behov av 
skalpblodprov hade 1496 kvinnor lottats till analys av laktat och 1496 kvinnor till pH-
analys.  
Vi undersökte utfallet för fostren med den mest uttalade graden av pH-sänkning 
respektive laktatkoncentrations-stegring i skalpblod. Beräkning av den 95:e percentilen 
i laktat-analysgruppen och den 5:e percentilen i pH-analys-gruppen gav gränsvärdena 
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laktatkoncentration 6.6 mmol/l samt pH värde 7.17, och värden över respektive under 
dessa nivåer definierades som allvarlig surhetsgrad i blodet under förlossning.  
154 foster hade skalpblodprovsvärden utanför dessa gränser, och barnutfallet i denna 
högriskgrupp visade ändock låg risk för allvarlig nyföddhetskomplikation. Av de 154 
nyfödda i denna högrisk-grupp hade 7.8% ett pH-värde < 7.00 i navelsträngsartär, 
10,4% hade Apgar-poäng < 7 vid 5 minuters ålder och 2.6% hade syrebristrelaterad 
neurologisk påverkan i nyföddhetsperioden. Det förelåg ingen skillnad mellan barnen 
där pH analyserats och barnen som genomgått analys av laktat. Dock var tiden från 
provtagning till förlossning kortare i gruppen med pH-analys. Huvudorsaken till detta 
är sannolikt att fler blev vaginalförlösta i gruppen med pH-analys. Huruvida 
förlossningen avslutas med kejsarsnitt eller vaginalt med sugklocka eller tång, beror på 
i vilket skede av förlossningen som den för fostret hotande situationen har uppstått, och 
den fördelningen kan inte ha påverkats av analys-typ i en randomiserad studie, utan 
skillnaden i förlossningssätt mellan grupperna tolkas som orsakad av slumpen. Däremot 
kan det lika goda utfallet för barnen i båda grupperna trots tidsskillnaden till förlossning 
tolkas som att laktat är en tidigare markör än pH för begynnande syrebrist.  
Studiens slutsats är att skalpblodprovstagning kan användas för att förebygga 
syrebristrelaterade nyföddhetskomplikationer och att risken för dessa är låga även vid 
uttalad surhetsgrad i blodet hos fostret vid skalpblodprovstagning. 
 
Laktatproduktion som svar på syrebrist under förlossning hos det tillväxthämmade 
fostret – Studie II 
Delarbete II är en subanalys av samma randomiserade studie som ovan, med de kvinnor 
som lottats till analys av laktat som studiepopulation. Tillväxthämmade foster är 
känsligare för syrebrist under förlossning än normalstora foster. De har inte depåer av 
reservenergi i form av lagrat socker som normalstora foster har och är därför sämre 
rustade att klara den påfrestning som värkarna under förlossning utgör. Eftersom laktat 
bara bildas vid nedbrytning av socker, var vår hypotes att laktatkoncentrationen inte 
stiger i samma grad hos tillväxthämmade foster som hos normalstora foster vid en 
utveckling av syrebrist. Laktatkoncentrationen vid skalpblodprov skulle i så fall inte 
spegla graden av syrebrist hos de tillväxthämmade fostren som genomgår 
vaginalförlossning.  
Det fanns tillgängliga data på skalpblodprov hos 1354 av de 1496 randomiserade 
kvinnorna. Fostren delades in utifrån födelsevikt i grupperna liten/normal/stor för 
graviditetslängden (small for gestational age – SGA; appropriate for gestational age – 
AGA; large for gestational age – LGA). SGA användes som ersättningsmått för 
tillväxthämning. Grupperna jämfördes avseende laktatoncentration i skalpblod. Det 
förelåg ingen skillnad mellan viktgrupperna vad gäller andel foster med förhöjd 
laktatkoncentration i blodet vid skalpblodprovstagning. SGA-fostren hade något högre 
medelvärde än AGA-fostren, och detta kan tolkas som ett uttryck för en kronisk 
låggradig syrebrist. Vid analys av fostren med laktatnivåer över gränsvärdet för acidemi 
(surt blod), 4,8 mmol/l, sågs att SGA-fostren ökade sin laktatproduktion i samma grad 
som AGA-fostren. Vid analys av SGA-gruppens laktatnivåer fanns en svag men 
signifikant korrelation mellan fosterstorlek och laktatkoncentration, som visade att ju 
mindre foster desto högre laktatnivåer. Detta ger stöd för att även fostren med störst 
viktavvikelse kan svara adekvat på syrebrist med laktatproduktion. 
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Skalpblodprovstagning med laktatanalys är därför en säker övervakningsmetod även 
för tillväxthämmade foster som genomgår vaginalförlossning. 
 
CTG-mönster och risk för acidemi hos fostret under förlossning – Studie III 
Delarbete III är en prospektiv observationsstudie av relationen mellan olika CTG-
avvikelser och förhöjd laktatnivå hos fostret. Flera CTG-mönster, såsom utdragen 
varaktighet av nedsatt variabilitet utan andra avvikelser, långvarig frånvaro av 
accelerationer (kortvariga uppgångar i hjärt-frekvensen) eller okomplicerade variabla 
decelerationer (kortvariga nedgångar i hjärtfrekvensen) med stor slagförlust, är av 
osäker patofysiologisk betydelse för fostret, men ger ofta upphov till oro för fostret hos 
övervakande barnmorskor och läkare. De studier som finns avseende sambandet mellan 
CTG-mönster och fosterpåverkan har små studiepopulationer, flera utfördes när CTG-
metoden fortfarande var relativt nyintroducerad, och definitionerna av olika parametrar 
i CTG-tolkning i de studierna skiljer sig från våra nuvarande riktlinjer. Utfallsmåtten 
var i flera fall pH-värdet i skalpblodprov hos fostret, vilket inte kan särskilja den 
allvarliga typen av acidemi från den ofarliga varianten som beror på en ansamling av 
koldioxid, men ingen syrebrist. Andra studier har undersökt sambandet med 
navelsträngsblodets syra-bas-balans, vilken påverkas av vilken åtgärd som företagits, 
samt tidsintervallet till födelsen. Ytterligare andra studier har undersökt sambandet med 
risk för cerebral pares, men syrebrist under förlossning utgör bara en mindre del av 
många orsaker till cerebral pares.  
Vi såg det därför intressant att undersöka sambandet mellan olika CTG-avvikelser och 
förhöjd mjölksyrehalt i fosterblod under förlossning.  
Under studietiden utfördes skalpblodprovstagning i 1070 förlossningar, vilka utgjorde 
cirka 11 % av samtliga förlossningar på den aktuella förlossningskliniken. Ett CTG-
mönster med nedsatt variabilitet som enda avvikelse var inte associerat med högre 
laktatkoncentration eller ökad förekomst av laktatkoncentration över den satta 
normalgränsen jämfört med ett normalt CTG-mönster. De två typerna av allvarliga 
decelerationer orsakade, trots olika ursprung, lika stora andelar av laktatkoncentration 
över normalgränsen. Foster med förhöjd hjärtfrekvens i kombination med komplicerade 
variabla eller uniforma sena decelerationer hade det högsta medelvärdet på 
laktatkoncentrationen, och den högsta andelen av värden ovanför normalintervallet.  
 
Studieresultaten ger stöd för att flera vanliga anledningar till osäkerhet om fostrets 
välmående under förlossningen kan elimineras. Foster med isolerad nedsatt variabilitet 
under förlossning, behöver inte övervakas med upprepade skalpblodprover under 
förlossningen om ett enstaka prov har uteslutit pågående syrebristutveckling. Fyndet att 
de olika typerna av allvarliga decelerationer korrelerade lika till förhöjd 
mjölksyrekoncentration minskar också konsekvenserna av tolkningsvariationen mellan 
olika bedömare vad gäller beslut om åtgärder. 
 
Neonatalt utfall och förlossningssätt vid upprepad skalpblodprovstagning – Studie IV 
Delarbete IV är en prospektiv observationsstudie av relationen mellan antal skalpblod-
provstagningar och nyföddhetskomplikationer samt risk för kejsarsnitts-förlossning.  
Ibland uppstår måttliga CTG-förändringar tidigt i förlossningsförloppet, och i vissa fall 
föreligger ett utdraget förlossningsförlopp med måttliga CTG-förändringar som inte är 
så allvarliga att de leder till beslut om omedelbar förlossning. Det finns inga klara 
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riktlinjer för upprepad skalpblodprovstagning vid dessa situationer och huruvida det 
finns en övre gräns för vad som är säkert ur fostrets och lämpligt ur den födande 
kvinnans synpunkt. Vi undersökte därför om det fanns någon skillnad i utfall för barnen 
och i förlossningssätt mellan de förlossningar där enstaka (1-2) skalpblodprov tagits 
och de med upprepade provtagningar (3 eller fler).  I gruppen med upprepade prover 
var medelvärdet av laktatkoncentrationen vid skalpblodprovstagning högre än i 
gruppen med enstaka prov, och andelen med förhöjda laktatnivåer var också högre. 
Dock var det ingen skillnad mellan grupperna vad gäller andel barn med låga Apgar-
poäng, pH < 7.00 i navelsträngsartär, inläggning på neonatalvårdsavdelning eller 
neurologisk påverkan i nyföddhetsperioden. Studieresultaten visade att det är säkert för 
fostret att fortsätta en vaginal förlossning vid CTG-förändringar när foster-
övervakningen kompletteras med upprepade skalpblodprover, då det möjliggör åtgärder 
och beslut om instrumentell eller kejsarsnittsförlossning i god tid innan risk för allvarlig 
påverkan i nyföddhetstiden uppstår.  
Vad gäller den födande kvinnan var kejsarsnittsfrekvensen nästan fördubblad (42 % 
jämfört med 23 %) bland de förlossningar där CTG-förändringar orsakat tre eller fler 
skalpblodprovstagningar jämfört med förlossningar där bara enstaka prov tagits. 
Riskökningen kontrollerades för kända förväxlingsfaktorer som kan ge ökad risk för 
kejsarsnittsförlossning såsom ålder > 35 år hos kvinnan, tidigare kejsarsnitt och 
överburenhet, men oddskvoten påverkades endast marginellt. Ändock ska poängteras 
att även i gruppen med upprepade skalpblodprovstagningar födde majoriteten (60 %) 
vaginalt, och 1/3 av dessa spontant. Studieresultaten är användbara i handläggandet av 
förlossningar där CTG-förändringar givit upphov till upprepade skalpblodprovs-
tagningar, när det gäller ställningstagande till fortsatt förlossning. 
 
Slutsats 
Vi har visat att skalpblodprovstagning med analys av laktatkoncentrationen är ett 
värdefullt komplement till CTG i fosterövervakning under förlossning. Analys av 
laktatnivåer i fosterblod är ett tillförlitligt sätt att utesluta utveckling av syrebrist när 
CTG-mönstret är avvikande.  
Vi har i ett stort material visat att flera CTG-avvikelser som ofta inger oro inte har 
samband med syrebristutveckling. Vi har också visat att två olika typer av nedgångar i 
hjärtfrekvensen som har olika orsaker, och ofta tolkas olika mellan olika bedömare, 
ändå har samma konsekvenser i fråga om laktatproduktion hos fostret. Detta kan 
minska variationen mellan olika CTG-tolkare i fråga om beslut om att ta skalpblodprov 
eller att avsluta förlossningen aktivt.  
Vi har visat att skalpblodsprovtagning med laktatanalys är en tillförlitlig 
övervakningsmetod även vid förlossningar av misstänkt tillväxthämmade foster.  
Att fortsätta en vaginal förlossning där måttliga CTG-förändringar föranleder upprepad 
skalpblodprovstagning är säkert för fostret, och orsakar inte ökad andel av 
syrebristrelaterade komplikationer i nyföddhetstiden. Däremot ökar risken för att 
förlossningen avslutas med kejsarsnitt. Dock föder majoriteten av kvinnorna vaginalt 
även när CTG-förändringar orsakat upprepad skalpblodprovstagning.  
Vi har visat att förhöjd laktatkoncentration i foster är en tidig markör i utveckling av 
syrebrist som gör det möjligt att förlösa barnet innan syrebristrelaterad skada sker. 
Även hos foster med de allra högsta nivåerna av laktat i blodet är risken för 
syrebristrelaterad nyföddhetskomplikation låg när adekvata åtgärder vidtas.  
   57 
ACKNOWLEDGEMENTS 
I want to express my deepest gratitude to everyone who have helped and supported me 
during the process of working with this thesis. I would especially like to thank: 
 
Associate professor Lennart Nordström, my main supervisor, for introducing me to 
science and sharing your huge knowledge of fetal surveillance as well as your great 
enthusiasm for a scientific approach in the obstetric field, often difficult to objectively 
evaluate. During all those hours of CTG interpretation we have also come to discuss 
many clinical aspects, and you have become an inspiring clinical mentor. Your 
encouraging believe in me has really made me grow as a scientist and a clinician. 
 
Professor Sven Cnattingius, my co-supervisor, for sharing your vast knowledge of 
epidemiology, and being an important input in study design as well as in the writing 
process. You have been a great support in reading and correcting my manuscripts. 
 
Åsa Wijkström, head of the Department of Obstetrics and Gynecology at Karolinska 
University Hospital, for kindness and wish to enable a good working and research 
atmosphere. 
 
Marianne van Rooijen, former head of the Department of Obstetrics and Gynecology at 
Karolinska University Hospital, for encouragement and friendship during both clinical 
and research work. 
 
Charlotta Grunewald, head of the Department of Obstetrics at Karolinska University 
Hospital, for showing interest in both my progress as a clinician and giving enthusiastic 
support to my research.  
 
Annette Aronsson, former head of the Department of Obstetrics at Karolinska 
University, for being such a warm and caring colleague.   
 
Stina Wretler, my co-author and colleague, for your enthusiasm when entering in our 
research group and helping me completing our large data-set, never complaining when 
a new variable was added. 
 
Hans Järnbert Pettersson, statistician at Södersjukhuset, for valuable and educational 
discussions on how to approach and treat our material, always with the aim to search 
and present the truth. 
 
All my dear colleagues and friends at the Department of Obstetrics and Gynecology at 
Karolinska University Hospital, for great friendship and supportive atmosphere, and 
thank to all colleagues who loyally remembered my ongoing study whenever there was 
a FBS to be taken during on-call duties. 
I need to especially mention my dear room-mate Katarina Remaeus, for all your wise 
thoughts, your never ending care and support ever since we started off as residents, 
Sophie Graner we’ve also shared all these years, thank you for your fantastic humour 
and warmth, and as the scheduler for, in an almost magic way, putting together all those 
 58 
ALF-weeks for me, I also want to especially thank my dear colleague and friend Ingela 
Hulthén Varli for your enthusiastic engagement in my research, and all your invaluable 
tips and tricks in the final writing process. 
 
My co-members in our fantastic ”CTG education group” at Karolinska University 
Hospital Solna – Cecilia Lind, Susanne Falck and Huda Muhammed Awel – thank you 
so much for all the vivid and interesting discussions about CTG patterns and various 
clinically challenging cases, I have learned so much during this process. 
 
All midwives and assistant nurses at the labor ward at Karolinska University Hospital, 
for always making our department such an enjoyable workplace, and for helping out 
reminding colleagues of the FBS Study. 
 
My dear friend Mika Skeppholm, for all fun moments during the years of internship, 
and afterwards as mums on maternal leave. When I was lost and hesitant regarding my 
future career, you reminded me of my interest in Gynecology back during med. school, 
– I don’t think I would be here if it wasn’t for you. 
 
Dear friends all way back from childhood, Kicki Widsing - no one understands a 
‘hockey-morsa’ as another ‘hockey-morsa’, and Kristina Edmondson, I carry the 
memories of our deep talks about life, death, God and peace on earth in the schoolyard; 
although we meet too seldom nowadays, we pick up as if we spoke yesterday. 
 
All dear beloved friends, you are too many to mention, I am deeply grateful to you for 
being part of my life and sharing good times. 
 
All members of Riddarholmens kammarkör, you make life so much richer, thank you 
for sharing all the wonderful music, and so many hilarious moments. 
 
My father and mother, Gunnar and Sylvia, thank you for your endless support and 
unconditional love. 
 
My brothers Jan, David and Pontus, and families, thank you for always being there. 
 
My Most Beloved Sister Rakel, for your enormous warmth and care, for always having 
time to help out when I need you, and for drawing the beautiful picture of fetal 
circulation… twice – since I gave you the wrong details… 
 
My wonderful children, Samuel, Elias and Hannah, I love you with all my heart 
 
My husband, my love, Martin, you make life…. exciting 
 
 
 
The studies were financially supported by Signhild Engkvist Foundation and 
Stockholm County Council (ALF project) 
   59 
REFERENCES 
 
 
1. Alfirevic Z, Devane D, Gyte GM. Continuous cardiotocography (CTG) as a form 
of electronic fetal monitoring (EFM) for fetal assessment during labour. Cochrane 
Database Syst Rev. 2013;5:CD006066. 
2. Surveillance of cerebral palsy in Europe: a collaboration of cerebral palsy surveys 
and registers. Surveillance of Cerebral Palsy in Europe (SCPE). Dev Med Child 
Neurol. 2000 Dec;42(12):816-24. 
3. Holzmann M, Nordstrom L. Follow-up national survey (Sweden) of routines for 
intrapartum fetal surveillance. Acta Obstetricia Et Gynecologica Scandinavica. 
2010 May;89(5):712-4. 
4. Heinis AM, Spaanderman ME, Gunnewiek JM, Lotgering FK. Scalp blood lactate 
for intra-partum assessment of fetal metabolic acidosis. Acta Obstet Gynecol 
Scand. 2011 Oct;90(10):1107-14. 
5. Goodwin TM, Milner-Masterson L, Paul RH. Elimination of fetal scalp blood 
sampling on a large clinical service. Obstet Gynecol. 1994 Jun;83(6):971-4. 
6. Sorensen A, Holm D, Pedersen M, Tietze A, Stausbol-Gron B, Duus L, et al. Left-
right difference in fetal liver oxygenation during hypoxia estimated by BOLD MRI 
in a fetal sheep model. Ultrasound in obstetrics & gynecology : the official journal 
of the International Society of Ultrasound in Obstetrics and Gynecology. 2011 
Dec;38(6):665-72. 
7. Edelstone DI, Rudolph AM. Preferential streaming of ductus venosus blood to the 
brain and heart in fetal lambs. Am J Physiol. 1979 Dec;237(6):H724-9. 
8. Kiserud T, Acharya G. The fetal circulation. Prenatal diagnosis. 2004 Dec 
30;24(13):1049-59. 
9. Nijland R, Jongsma HW, Nijhuis JG, van den Berg PP, Oeseburg B. Arterial 
oxygen saturation in relation to metabolic acidosis in fetal lambs. Am J Obstet 
Gynecol. 1995 Mar;172(3):810-9. 
10. Sheldon RE, Peeters LL, Jones MD, Jr., Makowski EL, Meschia G. Redistribution 
of cardiac output and oxygen delivery in the hypoxemic fetal lamb. Am J Obstet 
Gynecol. 1979 Dec 15;135(8):1071-8. 
11. Peeters LL, Sheldon RE, Jones MD, Jr., Makowski EL, Meschia G. Blood flow to 
fetal organs as a function of arterial oxygen content. Am J Obstet Gynecol. 1979 
Nov 1;135(5):637-46. 
12. Li H, Gudmundsson S, Olofsson P. Acute centralization of blood flow in 
compromised human fetuses evoked by uterine contractions. Early Hum Dev. 2006 
Nov;82(11):747-52. 
13. Rurak DW, Gruber NC. The effect of neuromuscular blockade on oxygen 
consumption and blood gases in the fetal lamb. Am J Obstet Gynecol. 1983 Jan 
15;145(2):258-62. 
14. Vintzileos AM, Fleming AD, Scorza WE, Wolf EJ, Balducci J, Campbell WA, et 
al. Relationship between fetal biophysical activities and umbilical cord blood gas 
values. Am J Obstet Gynecol. 1991 Sep;165(3):707-13. 
15. Richardson BS. The fetal brain: metabolic and circulatory responses to asphyxia. 
Clinical and investigative medicine Medecine clinique et experimentale. 1993 
Apr;16(2):103-14. 
16. Rooth G. Perinatal acid-base balance. Lund: Studentlitteratur; 1988. 
 60 
17. Burd LI, Jones MD, Jr., Simmons MA, Makowski EL, Meschia G, Battaglia 
FC. Placental production and foetal utilisation of lactate and pyruvate. Nature. 
1975 Apr 24;254(5502):710-1. 
18. Rooth G. Perinatal acid-base balance. Lund: Studentlitteratur; 1988. 
19. Low JA, Pancham SR, Worthington D, Boston RW. Acid-base, lactate, and 
pyruvate characteristics of the normal obstetric patient and fetus during the 
intrapartum period. Am J Obstet Gynecol. 1974 Dec 1;120(7):862-7. 
20. Low JA, Galbraith RS, Muir DW, Killen HL, Pater EA, Karchmar EJ. The 
relationship between perinatal hypoxia and newborn encephalopathy. Am J 
Obstet Gynecol. 1985 Jun 1;152(3):256-60. 
21. Low JA, Panagiotopoulos C, Derrick EJ. Newborn complications after 
intrapartum asphyxia with metabolic acidosis in the term fetus. Am J Obstet 
Gynecol. 1994 Apr;170(4):1081-7. 
22. Wiberg N, Kallen K, Olofsson P. Base deficit estimation in umbilical cord 
blood is influenced by gestational age, choice of fetal fluid compartment, and 
algorithm for calculation. Am J Obstet Gynecol. 2006 Dec;195(6):1651-6. 
23. Milley JR. Uptake of exogenous substrates during hypoxia in fetal lambs. Am J 
Physiol. 1988 May;254(5 Pt 1):E572-8. 
24. Piquard F, Schaefer A, Dellenbach P, Haberey P. Is fetal acidosis in the human 
fetus maternogenic during labor? A reanalysis. Am J Physiol. 1991 Nov;261(5 
Pt 2):R1294-9. 
25. Piquard F, Schaefer A, Hsiung R, Dellenbach P, Haberey P. Are there two 
biological parts in the second stage of labor? Acta Obstet Gynecol Scand. 
1989;68(8):713-8. 
26. Nicolaides KH, Economides DL, Soothill PW. Blood gases, pH, and lactate in 
appropriate- and small-for-gestational-age fetuses. Am J Obstet Gynecol. 1989 
Oct;161(4):996-1001. 
27. Bax M, Nelson KB. Birth asphyxia: a statement. World Federation of 
Neurology Group. Dev Med Child Neurol. 1993 Nov;35(11):1022-4. 
28. Low JA. Metabolic acidosis and fetal reserve. Baillieres Clin Obstet Gynaecol. 
1996 Jun;10(2):211-24. 
29. MacLennan A. A template for defining a causal relation between acute 
intrapartum events and cerebral palsy: international consensus statement. BMJ. 
1999 Oct 16;319(7216):1054-9. 
30. Gluckman PD, Williams CE. When and why do brain cells die? Dev Med Child 
Neurol. 1992 Nov;34(11):1010-4. 
31. Williams CE, Gunn AJ, Mallard C, Gluckman PD. Outcome after ischemia in 
the developing sheep brain: an electroencephalographic and histological study. 
Ann Neurol. 1992 Jan;31(1):14-21. 
32. Hagberg H, Thornberg E, Blennow M, Kjellmer I, Lagercrantz H, Thiringer K, 
et al. Excitatory amino acids in the cerebrospinal fluid of asphyxiated infants: 
relationship to hypoxic-ischemic encephalopathy. Acta Paediatr. 1993 
Nov;82(11):925-9. 
33. Hagberg H, Mallard C, Rousset CI, Thornton C. Mitochondria: hub of injury 
responses in the developing brain. Lancet neurology. 2014 Feb;13(2):217-32. 
34. Blomgren K, Hagberg H. Free radicals, mitochondria, and hypoxia-ischemia in 
the developing brain. Free radical biology & medicine. 2006 Feb 1;40(3):388-
97. 
35. van Bel F, Groenendaal F. Long-term pharmacologic neuroprotection after birth 
asphyxia: where do we stand? Neonatology. 2008;94(3):203-10. 
36. Blair E, Stanley FJ. Intrapartum asphyxia: a rare cause of cerebral palsy. J 
Pediatr. 1988 Apr;112(4):515-9. 
   61 
37. Blair E, Stanley F. When can cerebral palsy be prevented? The generation of 
causal hypotheses by multivariate analysis of a case-control study. Paediatr 
Perinat Epidemiol. 1993 Jul;7(3):272-301. 
38. Nelson KB, Leviton A. How much of neonatal encephalopathy is due to birth 
asphyxia? American journal of diseases of children. 1991 Nov;145(11):1325-
31. 
39. Adamson SJ, Alessandri LM, Badawi N, Burton PR, Pemberton PJ, Stanley F. 
Predictors of neonatal encephalopathy in full-term infants. BMJ. 1995 Sep 
2;311(7005):598-602. 
40. Badawi N, Kurinczuk JJ, Keogh JM, Alessandri LM, O'Sullivan F, Burton PR, 
et al. Antepartum risk factors for newborn encephalopathy: the Western 
Australian case-control study. BMJ. 1998 Dec 5;317(7172):1549-53. 
41. Badawi N, Kurinczuk JJ, Keogh JM, Alessandri LM, O'Sullivan F, Burton PR, 
et al. Intrapartum risk factors for newborn encephalopathy: the Western 
Australian case-control study. BMJ. 1998 Dec 5;317(7172):1554-8. 
42. Himmelmann K, Hagberg G, Beckung E, Hagberg B, Uvebrant P. The 
changing panorama of cerebral palsy in Sweden. IX. Prevalence and origin in 
the birth-year period 1995-1998. Acta Paediatr. 2005 Mar;94(3):287-94. 
43. Odding E, Roebroeck ME, Stam HJ. The epidemiology of cerebral palsy: 
incidence, impairments and risk factors. Disabil Rehabil. 2006 Feb 
28;28(4):183-91. 
44. Gilstrap LC, 3rd, Leveno KJ, Burris J, Williams ML, Little BB. Diagnosis of 
birth asphyxia on the basis of fetal pH, Apgar score, and newborn cerebral 
dysfunction. Am J Obstet Gynecol. 1989 Sep;161(3):825-30. 
45. Goldaber KG, Gilstrap LC, 3rd, Leveno KJ, Dax JS, McIntire DD. Pathologic 
fetal acidemia. Obstet Gynecol. 1991 Dec;78(6):1103-7. 
46. Ingemarsson I, Herbst A, Thorngren-Jerneck K. Long term outcome after 
umbilical artery acidaemia at term birth: influence of gender and duration of 
fetal heart rate abnormalities. Br J Obstet Gynaecol. 1997 Oct;104(10):1123-7. 
47. Low JA, Panagiotopoulos C, Derrick EJ. Newborn complications after 
intrapartum asphyxia with metabolic acidosis in the preterm fetus. Am J Obstet 
Gynecol. 1995 Mar;172(3):805-10. 
48. Low JA, Galbraith RS, Muir DW, Killen HL, Pater EA, Karchmar EJ. Motor 
and cognitive deficits after intrapartum asphyxia in the mature fetus. Am J 
Obstet Gynecol. 1988 Feb;158(2):356-61. 
49. Low JA, Galbraith RS, Muir DW, Killen HL, Pater EA, Karchmar EJ. Mortality 
and morbidity after intrapartum asphyxia in the preterm fetus. Obstet Gynecol. 
1992 Jul;80(1):57-61. 
50. Hon EH, Hess OW. Instrumentation of fetal electrocardiography. Science. 1957 
Mar 22;125(3247):553-4. 
51. Hammacher K. [New method for the selective registration of the fetal heart 
beat]. Geburtshilfe Frauenheilkd. 1962 Dec;22:1542-43. 
52. MacDonald D, Grant A, Sheridan-Pereira M, Boylan P, Chalmers I. The Dublin 
randomized controlled trial of intrapartum fetal heart rate monitoring. Am J 
Obstet Gynecol. 1985 Jul 1;152(5):524-39. 
53. Grant A, O'Brien N, Joy MT, Hennessy E, MacDonald D. Cerebral palsy 
among children born during the Dublin randomised trial of intrapartum 
monitoring. Lancet. 1989 Nov 25;2(8674):1233-6. 
54. Vintzileos AM, Antsaklis A, Varvarigos I, Papas C, Sofatzis I, Montgomery JT. 
A randomized trial of intrapartum electronic fetal heart rate monitoring versus 
intermittent auscultation. Obstet Gynecol. 1993 Jun;81(6):899-907. 
 62 
55. Vintzileos AM, Nochimson DJ, Guzman ER, Knuppel RA, Lake M, Schifrin 
BS. Intrapartum electronic fetal heart rate monitoring versus intermittent 
auscultation: a meta-analysis. Obstet Gynecol. 1995 Jan;85(1):149-55. 
56. International Federation of Gynaecology & Obstetrics, Rooth G, Huch A, Huch 
R. Guidelines for the use of fetal monitoring. Int J Gynaecol Obstet. 
1987;25:159-67. 
57. National Institute for Clinical Excellence. Intrapartum care: Care of healthy 
women and their babies during childbirth. Manchester: National Institute for 
Health and Clinical Excellence; 2007. 
58. Royal Australian and New Zealand College of Obstetricians and 
Gynaecologists. Intrapartum Fetal Surveillance, Clinical Guidelines. Second ed. 
Melbourne, Australia: RANZCOG; 2006. 
59. American College of O, Gynecologists. ACOG Practice Bulletin No. 106: 
Intrapartum fetal heart rate monitoring: nomenclature, interpretation, and 
general management principles. Obstet Gynecol. 2009 Jul;114(1):192-202. 
60. Macones GA, Hankins GD, Spong CY, Hauth J, Moore T. The 2008 National 
Institute of Child Health and Human Development workshop report on 
electronic fetal monitoring: update on definitions, interpretation, and research 
guidelines. J Obstet Gynecol Neonatal Nurs. 2008 Sep-Oct;37(5):510-5. 
61. Liston R, Sawchuck D, Young D, Society of O, Gynaecologists of C, British 
Columbia Perinatal Health P. Fetal health surveillance: antepartum and 
intrapartum consensus guideline. J Obstet Gynaecol Can. 2007 Sep;29(9 Suppl 
4):S3-56. 
62. Parer JT, Ikeda T. A framework for standardized management of intrapartum 
fetal heart rate patterns. Am J Obstet Gynecol. 2007 Jul;197(1):26 e1-6. 
63. Okai T, Ikeda T, Kawarabayashi T, Kozuma S, Sugawara J, Chisaka H, et al. 
Intrapartum management guidelines based on fetal heart rate pattern 
classification. The journal of obstetrics and gynaecology research. 2010 
Oct;36(5):925-8. 
64. Swedish Society of Obstetrics and Gynecology. Guidelines for CTG 
interpretation and intervention. 
https://www.sfog.se/media/17094/ctg_kort__slutversion.pdf.  2009 
65. Ayres-de-Campos D, Bernardes J, Subcommittee F. Twenty-five years after the 
FIGO guidelines for the use of fetal monitoring: time for a simplified approach? 
Int J Gynaecol Obstet. 2010 Jul;110(1):1-6. 
66. Di Tommaso M, Seravalli V, Cordisco A, Consorti G, Mecacci F, Rizzello F. 
Comparison of five classification systems for interpreting electronic fetal 
monitoring in predicting neonatal status at birth. J Matern Fetal Neonatal Med. 
2013 Mar;26(5):487-90. 
67. Hon EH. The Classification of Fetal Heart Rate. I. A Working Classification. 
Obstet Gynecol. 1963 Aug;22:137-46. 
68. Liston R, Crane J, Hamilton E, Hughes O, Kuling S, MacKinnon C, et al. Fetal 
health surveillance in labour. J Obstet Gynaecol Can. 2002 Mar;24(3):250-76; 
quiz 77-80. 
69. Pildner von Steinburg S, Boulesteix AL, Lederer C, Grunow S, Schiermeier S, 
Hatzmann W, et al. What is the "normal" fetal heart rate? PeerJ. 2013;1:e82. 
70. Saling E. Amnioscopy and foetal blood sampling: observations on foetal 
acidosis. Arch Dis Child. 1966 Oct;41(219):472-6. 
71. Kubli FW, Hon EH, Khazin AF, Takemura H. Observations on heart rate and 
pH in the human fetus during labor. Am J Obstet Gynecol. 1969 Aug 
15;104(8):1190-206. 
   63 
72. Parer JT. The effect of acute maternal hypoxia on fetal oxygenation and the 
umbilical circulation in the sheep. Eur J Obstet Gynecol Reprod Biol. 1980 
Feb;10(2):125-36. 
73. Dalton KJ, Dawes GS, Patrick JE. The autonomic nervous system and fetal 
heart rate variability. Am J Obstet Gynecol. 1983 Jun 15;146(4):456-62. 
74. Van Geijn HP. Developments in CTG analysis. Baillieres Clin Obstet 
Gynaecol. 1996 Jun;10(2):185-209. 
75. Terao T, Kawashima Y, Noto H, Inamoto Y, Lin TY, Sumimoto K, et al. 
Neurological control of fetal heart rate in 20 cases of anencephalic fetuses. Am 
J Obstet Gynecol. 1984 May 15;149(2):201-8. 
76. Nelson KB, Dambrosia JM, Ting TY, Grether JK. Uncertain value of electronic 
fetal monitoring in predicting cerebral palsy. N Engl J Med. 1996 Mar 
7;334(10):613-8. 
77. Williams KP, Galerneau F. Intrapartum fetal heart rate patterns in the prediction 
of neonatal acidemia. Am J Obstet Gynecol. 2003 Mar;188(3):820-3. 
78. Sadovsky E, Rabinowitz R, Freeman A, Yarkoni S. The relationship between 
fetal heart rate accelerations, fetal movements, and uterine contractions. Am J 
Obstet Gynecol. 1984 May 15;149(2):187-9. 
79. Skupski DW, Eglinton GS. Intrapartum fetal stimulation tests: a meta-analysis. 
Obstet Gynecol. 2002 Oct;100(4):830. 
80. Sholapurkar SL. The conundrum of vanishing early decelerations in British 
obstetrics, a step backwards? Detailed appraisal of British and American 
classifications of fetal heart rate decelerations - fallacies of emphasis on 
waveform and putative aetiology. J Obstet Gynaecol. 2012 Aug;32(6):505-11. 
81. Hamilton E, Warrick P, O'Keeffe D. Variable decelerations: do size and shape 
matter? J Matern Fetal Neonatal Med. 2012 Jun;25(6):648-53. 
82. Bernardes J, Costa-Pereira A, Ayres-de-Campos D, van Geijn HP, Pereira-Leite 
L. Evaluation of interobserver agreement of cardiotocograms. Int J Gynaecol 
Obstet. 1997 Apr;57(1):33-7. 
83. Hon EH, Quilligan EJ. The classification of fetal heart rate. II. A revised 
working classification. Connecticut medicine. 1967 Nov;31(11):779-84. 
84. Myers RE. Two patterns of perinatal brain damage and their conditions of 
occurrence. Am J Obstet Gynecol. 1972 Jan 15;112(2):246-76. 
85. Parer JT, Krueger TR, Harris JL. Fetal oxygen consumption and mechanisms of 
heart rate response during artificially produced late decelerations of fetal heart 
rate in sheep. Am J Obstet Gynecol. 1980 Feb 15;136(4):478-82. 
86. Ellison PH, Foster M, Sheridan-Pereira M, MacDonald D. Electronic fetal heart 
monitoring, auscultation, and neonatal outcome. Am J Obstet Gynecol. 1991 
May;164(5 Pt 1):1281-9. 
87. Fleischer A, Schulman H, Jagani N, Mitchell J, Randolph G. The development 
of fetal acidosis in the presence of an abnormal fetal heart rate tracing. I. The 
average for gestational age fetus. Am J Obstet Gynecol. 1982 Sep 1;144(1):55-
60. 
88. Althaus JE, Petersen SM, Fox HE, Holcroft CJ, Graham EM. Can electronic 
fetal monitoring identify preterm neonates with cerebral white matter injury? 
Obstet Gynecol. 2005 Mar;105(3):458-65. 
89. de Haan HH, Gunn AJ, Gluckman PD. Fetal heart rate changes do not reflect 
cardiovascular deterioration during brief repeated umbilical cord occlusions in 
near-term fetal lambs. Am J Obstet Gynecol. 1997 Jan;176(1 Pt 1):8-17. 
90. Bennet L, Westgate JA, Liu YC, Wassink G, Gunn AJ. Fetal acidosis and 
hypotension during repeated umbilical cord occlusions are associated with 
 64 
enhanced chemoreflex responses in near-term fetal sheep. Journal of applied 
physiology (Bethesda, Md : 1985). 2005 Oct;99(4):1477-82. 
91. Westgate JA, Wibbens B, Bennet L, Wassink G, Parer JT, Gunn AJ. The 
intrapartum deceleration in center stage: a physiologic approach to the 
interpretation of fetal heart rate changes in labor. Am J Obstet Gynecol. 2007 
Sep;197(3):236 e1-11. 
92. Sameshima H, Ikenoue T, Ikeda T, Kamitomo M, Ibara S. Unselected low-risk 
pregnancies and the effect of continuous intrapartum fetal heart rate monitoring 
on umbilical blood gases and cerebral palsy. Am J Obstet Gynecol. 2004 
Jan;190(1):118-23. 
93. Parer JT, King T, Flanders S, Fox M, Kilpatrick SJ. Fetal acidemia and 
electronic fetal heart rate patterns: Is there evidence of an association? Journal 
of Maternal-Fetal & Neonatal Medicine. 2006 May;19(5):289-94. 
94. Cibils LA. Clinical significance of fetal heart rate patterns during labor. VI. 
Early decelerations. Am J Obstet Gynecol. 1980 Feb 1;136(3):392-8. 
95. Peebles DM, Edwards AD, Wyatt JS, Bishop AP, Cope M, Delpy DT, et al. 
Changes in human fetal cerebral hemoglobin concentration and oxygenation 
during labor measured by near-infrared spectroscopy. Am J Obstet Gynecol. 
1992 May;166(5):1369-73. 
96. Chua S, Kurup A, Arulkumaran S, Ratnam SS. Augmentation of labor: does 
internal tocography result in better obstetric outcome than external tocography? 
Obstet Gynecol. 1990 Aug;76(2):164-7. 
97. Nielsen PV, Stigsby B, Nickelsen C, Nim J. Intra- and inter-observer variability 
in the assessment of intrapartum cardiotocograms. Acta Obstet Gynecol Scand. 
1987;66(5):421-4. 
98. Beaulieu MD, Fabia J, Leduc B, Brisson J, Bastide A, Blouin D, et al. The 
reproducibility of intrapartum cardiotocogram assessments. Canadian Medical 
Association journal. 1982 Aug 1;127(3):214-6. 
99. Ayres-de-Campos D, Bernardes J, Costa-Pereira A, Pereira-Leite L. 
Inconsistencies in classification by experts of cardiotocograms and subsequent 
clinical decision. Br J Obstet Gynaecol. 1999 Dec;106(12):1307-10. 
100. Devane D, Lalor J. Midwives' visual interpretation of intrapartum 
cardiotocographs: intra- and inter-observer agreement. J Adv Nurs. 2005 
Oct;52(2):133-41. 
101. Hayashi M, Nakai A, Sekiguchi A, Takeshita T. Fetal heart rate classification 
proposed by the perinatology committee of the Japan Society of Obstetrics and 
Gynecology: reproducibility and clinical usefulness. Journal of Nippon Medical 
School = Nippon Ika Daigaku zasshi. 2012;79(1):60-8. 
102. Epstein AJ, Twogood S, Lee RH, Opper N, Beavis A, Miller DA. Interobserver 
reliability of fetal heart rate pattern interpretation using NICHD definitions. Am 
J Perinatol. 2013 Jun;30(6):463-8. 
103. Bretscher J, Saling E. pH values in the human fetus during labor. Am J Obstet 
Gynecol. 1967 Apr 1;97(7):906-11. 
104. Ingemarsson I, Arulkumaran S. Fetal acid-base balance in low-risk patients in 
labor. Am J Obstet Gynecol. 1986 Jul;155(1):66-9. 
105. Westgren M, Kruger K, Ek S, Grunevald C, Kublickas M, Naka K, et al. 
Lactate compared with pH analysis at fetal scalp blood sampling: a prospective 
randomised study. Br J Obstet Gynaecol. 1998 Jan;105(1):29-33. 
106. Tuffnell D, Haw WL, Wilkinson K. How long does a fetal scalp blood sample 
take? BJOG. 2006 Mar;113(3):332-4. 
   65 
107. Smith NC, Quinn MC, Soutter WP, Sharp F. Rapid whole blood lactate 
measurement in the fetus and mother during labour. Early Hum Dev. 1979 
Mar;3(1):89-95. 
108. Eguiluz A, Lopez Bernal A, McPherson K, Parrilla JJ, Abad L. The use of 
intrapartum fetal blood lactate measurements for the early diagnosis of fetal 
distress. Am J Obstet Gynecol. 1983 Dec 15;147(8):949-54. 
109. Nordstrom L, Persson B, Shimojo N, Westgren M. Fetal scalp and umbilical 
artery blood lactate measured with a new test strip method. Br J Obstet 
Gynaecol. 1992 Apr;99(4):307-9. 
110. Nordstrom L, Ingemarsson I, Persson B, Shimojo N, Westgren M. Lactate in 
fetal scalp blood and umbilical artery blood measured during normal labor with 
a test strip method. Acta Obstet Gynecol Scand. 1994 Mar;73(3):250-4. 
111. Nordstrom L, Ingemarsson I, Kublickas M, Persson B, Shimojo N, Westgren 
M. Scalp blood lactate: a new test strip method for monitoring fetal wellbeing in 
labour. Br J Obstet Gynaecol. 1995 Nov;102(11):894-9. 
112. Helwig JT, Parer JT, Kilpatrick SJ, Laros RK, Jr. Umbilical cord blood acid-
base state: what is normal? Am J Obstet Gynecol. 1996 Jun;174(6):1807-12; 
discussion 12-4. 
113. Low JA. The role of blood gas and acid-base assessment in the diagnosis of 
intrapartum fetal asphyxia. Am J Obstet Gynecol. 1988 Nov;159(5):1235-40. 
114. Kastendieck E, Paulick R, Martius J. Lactate in fetal tissue during hypoxia; 
correlation to lactate, pH and base deficit in the fetal blood. Eur J Obstet 
Gynecol Reprod Biol. 1988 Sep;29(1):61-71. 
115. Engidawork E, Chen Y, Dell'Anna E, Goiny M, Lubec G, Ungerstedt U, et al. 
Effect of perinatal asphyxia on systemic and intracerebral pH and glycolysis 
metabolism in the rat. Exp Neurol. 1997 Jun;145(2 Pt 1):390-6. 
116. Amer-Wahlin I, Nord A, Bottalico B, Hansson SR, Ley D, Marsal K, et al. Fetal 
cerebral energy metabolism and electrocardiogram during experimental 
umbilical cord occlusion and resuscitation. J Matern Fetal Neonatal Med. 2010 
Feb;23(2):158-66. 
117. Kruger K, Kublickas M, Westgren M. Lactate in scalp and cord blood from 
fetuses with ominous fetal heart rate patterns. Obstet Gynecol. 1998 
Dec;92(6):918-22. 
118. Borruto F, Comparetto C, Treisser A. Prevention of cerebral palsy during 
labour: role of foetal lactate. Arch Gynecol Obstet. 2008 Jul;278(1):17-22. 
119. Nordstrom L, Marcus C, Persson B, Shimojo N, Westgren M. Lactate in cord 
blood and its relationship to pH and catecholamines in spontaneous vaginal 
deliveries. Early Hum Dev. 1996 Sep 20;46(1-2):97-104. 
120. Linet T, Laporte J, Gueye H, Boog G. [Microvolume dosage of lactate in cord 
blood for the evaluation of the neonatal well-being]. Journal de gynecologie, 
obstetrique et biologie de la reproduction. 2002 Jun;31(4):352-7. 
121. Gjerris AC, Staer-Jensen J, Jorgensen JS, Bergholt T, Nickelsen C. Umbilical 
cord blood lactate: a valuable tool in the assessment of fetal metabolic acidosis. 
Eur J Obstet Gynecol Reprod Biol. 2008 Jul;139(1):16-20. 
122. Low JA. Intrapartum fetal asphyxia: definition, diagnosis, and classification. 
Am J Obstet Gynecol. 1997 May;176(5):957-9. 
123. da Silva S, Hennebert N, Denis R, Wayenberg JL. Clinical value of a single 
postnatal lactate measurement after intrapartum asphyxia. Acta Paediatr. 2000 
Mar;89(3):320-3. 
124. Kruger K, Hallberg B, Blennow M, Kublickas M, Westgren M. Predictive value 
of fetal scalp blood lactate concentration and pH as markers of neurologic 
disability. Am J Obstet Gynecol. 1999 Nov;181(5 Pt 1):1072-8. 
 66 
125. Ramanah R, Martin A, Clement MC, Maillet R, Riethmuller D. Fetal scalp 
lactate microsampling for non-reassuring fetal status during labor: a prospective 
observational study. Fetal diagnosis and therapy. 2010;27(1):14-9. 
126. Wiberg-Itzel E, Lipponer C, Norman M, Herbst A, Prebensen D, Hansson A, et 
al. Determination of pH or lactate in fetal scalp blood in management of 
intrapartum fetal distress: randomised controlled multicentre trial. BMJ. 2008 
Jun 7;336(7656):1284-7. 
127. Nordstrom L, Achanna S, Naka K, Arulkumaran S. Fetal and maternal lactate 
increase during active second stage of labour. BJOG. 2001 Mar;108(3):263-8. 
128. Nordstrom L. Fetal scalp and cord blood lactate. Best Pract Res Clin Obstet 
Gynaecol. 2004 Jun;18(3):467-76. 
129. Nordström L, Waldenström U. Handläggning av normal förlossning. In: 
Welfare TNBoHa, editor. Stockholm: Socialstyrelsen; 2001. p. 69. 
130. Westgate JA, Gunn AJ, Gunn TR. Antecedents of neonatal encephalopathy 
with fetal acidaemia at term. Br J Obstet Gynaecol. 1999 Aug;106(8):774-82. 
131. Nordstrom L, Arulkumaran S, Chua S, Ratnam S, Ingemarsson I, Kublickas M, 
et al. Continuous maternal glucose infusion during labor: effects on maternal 
and fetal glucose and lactate levels. Am J Perinatol. 1995 Sep;12(5):357-62. 
132. Nordstrom L, Chua S, Persson B, Naka K, Arulkumaran S. Intrapartum 
tocolysis has no effect on fetal lactate concentration. Eur J Obstet Gynecol 
Reprod Biol. 2000 Apr;89(2):165-8. 
133. Nordstrom L, Chua S, Roy A, Arulkumaran S. Quality assessment of two 
lactate test strip methods suitable for obstetric use. J Perinat Med. 
1998;26(2):83-8. 
134. Beard RW, Filshie GM, Knight CA, Roberts GM. The significance of the 
changes in the continuous fetal heart rate in the first stage of labour. The Journal 
of obstetrics and gynaecology of the British Commonwealth. 1971 
Oct;78(10):865-81. 
135. Westgren M, Divon M, Horal M, Ingemarsson I, Kublickas M, Shimojo N, et 
al. Routine measurements of umbilical artery lactate levels in the prediction of 
perinatal outcome. Am J Obstet Gynecol. 1995 Nov;173(5):1416-22. 
136. Holzmann M, Cnattingius S, Nordstrom L. Outcome of severe intrapartum 
acidemia diagnosed with fetal scalp blood sampling. J Perinat Med. 2011 
Sep;39(5):545-8. 
137. Westerhuis ME, Strasser SM, Moons KG, Mol BW, Visser GH, Kwee A. 
[Intrapartum foetal monitoring: from stethoscope to ST analysis of the ECG]. 
Nederlands tijdschrift voor geneeskunde. 2009;153:B259. 
138. Heazell AE, Riches J, Hopkins L, Myers JE. Fetal blood sampling in early 
labour: is there an increased risk of operative delivery and fetal morbidity? 
BJOG. 2011 Jun;118(7):849-55. 
139. Neilson JP. Fetal scalp sampling in labour. BMJ. 2008 Jun 7;336(7656):1257-8. 
140. Liljestrom L, Wikstrom AK, Skalkidou A, Akerud H, Jonsson M. Experience of 
fetal scalp blood sampling during labor. Acta Obstet Gynecol Scand. 2014 
Jan;93(1):113-7. 
141. Ojala K, Makikallio K, Haapsamo M, Ijas H, Tekay A. Interobserver agreement 
in the assessment of intrapartum automated fetal electrocardiography in 
singleton pregnancies. Acta Obstet Gynecol Scand. 2008;87(5):536-40. 
142. Westerhuis ME, van Horen E, Kwee A, van der Tweel I, Visser GH, Moons 
KG. Inter- and intra-observer agreement of intrapartum ST analysis of the fetal 
electrocardiogram in women monitored by STAN. BJOG. 2009 
Mar;116(4):545-51. 
   67 
143. Palomaki O, Luukkaala T, Luoto R, Tuimala R. Intrapartum cardiotocography -
- the dilemma of interpretational variation. J Perinat Med. 2006;34(4):298-302. 
 
 
 
